+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 42429

Chapter 42429 contains a list of PDF Full Texts available from EurekaMag.

Hörnsten, P.; Sundman-Engberg, B.; Gahrton, G.; Johansson, B., 1983:
CCNU toxicity after an overdose in a patient with Hodgkin's disease. Effects on colony-forming cells (CFU-C) and colony-stimulating activity (CSA)

García López, J.; Diumenjo, M.C.; Argüelles, M.V.; Marín, P.; Grañena, A.; Montserrat, E.; Rozman, C., 1980:
CCNU, bleomycin, and vincristine (vinblastine) combination therapy in the treatment of resistant lymphoma

Salimtschik, M.; Snel, S.; Havsteen, H.; Dombernowsky, P.; Mouridsen, H.T., 1980:
CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women

Poplin, E.A.; Aisner, J.; Van Echo, D.A.; Whitacre, M.; Wiernik, P.H., 1982:
CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma

Cianfriglia, F.; Pompili, A.; Riccio, A.; Grassi, A., 1980:
CCNU-chemotherapy of hemispheric supratentorial glioblastoma multiforme

McLaughlin, P.R., 1995:
CCS consensus conferences

Helmke, K.; Hausdorf, G.; Moehrs, D.; Laas, R., 1984:
CCT and sonographic findings in congenital craniopharyngioma

Hartman, J., 1968:
CCTV and tape recorders help extend the dietitian's "reach"

Ballantyne, D.J., 1974:
CCTV for patients

Anonymous, 1966:
CCTV gives this hospital new eyes

Anonymous, 1969:
CCTV is successfully applied in cobalt teletherapy

Anonymous, 1968:
CCTV takes patients into the kitchen

Anonymous, 1974:
CCU accommodates infants, children, adults

Suma, K.; Narumi, J., 1980:
CCU in Japan-- present status and problems

Takano, T.; Tanaka, K.; Endo, T.; Nagamine, K.; Katoh, T.; Hayakawa, H.; Hirosawa, K., 1984:
CCU network as primary care of acute myocardial infarction

Perrine, G.; Boudreau, M.C., 1970:
CCU nurse specialists

Schor, D.N., 1972:
CCU patients carry miniature ECG records

Fleming, H.A., 1965:
CCXVI. Long-acting isoprenaline

Goto, J.; Suzaki, K.; Ebihara, M.; Nambara, T.; Masu, A., 1985:
CCXVII. Separation and characterization of bile acid 3-glucuronides in human urine by high-performance liquid chromatography

Murray, I.P., 1967:
CCXXXIX. The current status of radioactive iodine

Ishii, K., 1971:
CCausative factor of coryza--with special reference to rhinovirus and coronaviruses

Fair, E.W., 1967:
CCheck the efficiency of your reception room

Valenzuela, C.Y., 1981:
CCl4 - induced liver cirrhosis, in the rat: effects of colchicine in its induction and recovery

Ebel, R.E.; McGrath, E.A., 1984:
CCl4-hepatotoxicity in the Mongolian gerbil: influence of monooxygenase system induction

Agarwal, A.K.; Mehendale, H.M., 1984:
CCl4-induced alterations in Ca++ homeostasis in chlordecone and phenobarbital pretreated animals

Archakov, A.I.; Karuzina, I.I., 1973:
CCl4-induced damage to endoplasmatic reticulum membranes

Stacey, N.H.; Ottenwälder, H.; Kappus, H., 1982:
CCl4-induced lipid peroxidation in isolated rat hepatocytes with different oxygen concentrations

Rechniewsky, C.; Ruiz, M.; Mazzei, C.M., 1967:
CClinical experience with tetracycline-1-methylene lysine

Chen, C.M.; Chung, C.F.; Tsai, L.C., 1971:
CCombined effect of phytohemagglutinin and antihymocyte serum on skin xenograft survival in mice

Ivanchenko, F.T., 1972:
CComplex therapy of coronary atherosclerosis

Urbanik, H.; Romanowska, A., 1968:
CCongenital pulmonary hypoplasia in children

Papanayiotou, P.; Kefakis, B.; Dontas, A.S., 1972:
CCreat and cIn in relation to urine flow in non-uremic subjects

Wilson, R.; Maclean, M.A.; Cumming, G.P.; Pearson, C.; Walker, J.J., 1993:
CD 5/20 positive cell numbers in patients with a history of miscarriage

Juy, M.; Lam-Thanh, H.; Fermandjian, S., 1982:
CD and 1H-n.m.r. studies on the side-chain conformation of tyrosine derivatives and tyrosine residues in di- and tripeptides

Schnellbacher, E.; Lumper, L., 1971:
CD and ORD spectra of cytochrome b5. Studies of cytochrome b5 from the microsomes of pig liver

Schmid, F.X., 1982:
CD properties of the fast- and slow-folding forms of unfolded ribonuclease A

Hollósi, M.; Dobolyi, Z.; Bajusz, S., 1980:
CD studies on enkephalin and its Pro5-analogs

Ajtai, K.; Venyaminov SYu, 1983:
CD study of the actin DNase I complex

Berean, K.W.; O'Connell, J.X.; Tron, V., 1995:
CD-34 expression

Blum, A.; Shohat, B., 1995:
CD-4 lymphopenia induced by streptokinase

Moubtakir, A.; Dejust, Sébastien.; Godard, Fçois.; Messaoud, L.; Morland, D., 2018:
18F-FDG PET/CT in Anti-NMDA Receptor Encephalitis: Typical Pattern and Follow-up

Era, S.; Ashida, H.; Nagaoka, S.; Inouye, H.; Sogami, M., 1983:
CD-resolved secondary structure of bovine plasma albumin in acid-induced isomerization

Pritchard, K.K.; Gordon, I.; Beverley, P.C.; Chu, A.C., 1993:
CD1 antibody immunolocalisation in Langerhans' cell histiocytosis

Hamzaoui, K.; Hentati, F.; Hamzaoui, A.; Kahan, A.; Ben Hamida, M.; Chabbou, A.; Ayed, K., 1994:
CD11/CD18 bearing lymphocytes in cerebrospinal fluid from patients with active Behçet's disease

Kim, Y.B.; Zhang, J.; Davis, W.C.; Lunney, J.K., 1994:
CD11/CD18 panel report for swine CD workshop

Pugin, J.; Heumann, I.D.; Tomasz, A.; Kravchenko, V.V.; Akamatsu, Y.; Nishijima, M.; Glauser, M.P.; Tobias, P.S.; Ulevitch, R.J., 1994:
CD14 is a pattern recognition receptor

Delude, R.L.; Fenton, M.J.; Savedra, R.; Perera, P.Y.; Vogel, S.N.; Thieringer, R.; Golenbock, D.T., 1994:
CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity

Kobayashi, S.; Yamamoto, T.; Akiba, C.; Katayama, N.; Sakai, K.; Yamaguchi, M.; Maruta, A.; Ogawa, K.; Fujisawa, S.; Sakai, R., 1993:
CD14-positive and nonspecific esterase-positive neutrophils in a patient with refractory anemia with excess of blasts in transformation

Längle, F.; Soliman, T.; Neuhold, N.; Widhalm, G.; Niederle, B.; Roka, S.; Kaserer, K.; Blauensteiner, W.; Dam, K.; Clodi, M., 1994:
CD15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? Study Group on Multiple Endocrine Neoplasia of Austria

Rosmarin, A.G.; Caprio, D.; Levy, R.; Simkevich, C., 1995:
CD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity

Ord, D.C.; Edelhoff, S.; Dushkin, H.; Zhou, L.J.; Beier, D.R.; Disteche, C.; Tedder, T.F., 1994:
CD19 maps to a region of conservation between human chromosome 16 and mouse chromosome 7

Lenormand, B.; Vannier, J.P.; Bene, M.C.; Falkenrodt, A.; Bayle, C.; Favre, M.; Garand, R.; Griveau, A.M.; Briquet, M.T.; Reman, O., 1993:
CD2 + CD19 + acute lymphoblastic leukaemia in 16 children and adults: clinical and biological features. Groupe d'Etude Immunologique des Leucémies (G.E.I.L.)

Savilo, E.; Meyer, R.M.; Soamboonsrup, P.; Sunisloe, L.; Frank, G.L.; Simon, G.T.; Neame, P.B., 1995:
CD2+, CD3-, CD56/NCAM+ malignant lymphoma with TCR beta gene rearrangement: a case report

de Waal Malefyt, R.; Verma, S.; Bejarano, M.T.; Ranes-Goldberg, M.; Hill, M.; Spits, H., 1993:
CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes

Bourget, I.; Di Berardino, W.; Breittmayer, J.P.; Grenier-Brossette, N.; Plana-Prades, M.; Bonnefoy, J.Y.; Cousin, J.L., 1995:
CD20 monoclonal antibodies decrease interleukin-4-stimulated expression of the low-affinity receptor for IgE (Fc epsilon RII/CD23) in human B cells by increasing the extent of its cleavage

Bourget, I.; Di Berardino, W.; Breittmayer, J.P.; Grenier-Brossette, N.; Plana-Prades, M.; Bonnefoy, J.Y.; Cousin, J.L., 1994:
CD20 monoclonal antibodies stimulate extracellular cleavage of the low affinity receptor for IgE (Fc epsilon RII/CD23) in Epstein-Barr-transformed B cells

Quintanilla-Martinez, L.; Preffer, F.; Rubin, D.; Ferry, J.A.; Harris, N.L., 1994:
CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset

Hanasaki, K.; Varki, A.; Powell, L.D., 1995:
CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins

Hanasaki, K., 1995:
CD22: a cell adhesion molecule that displays alpha 2-6-linked sialic acid-binding lectin activity

Lavabre-Bertrand, T.; Exbrayat, C.; Bourquard, P.; Lavabre-Bertrand, C.; Fégueux, N.; Poncelet, P.; Rousset, T.; Taïb, J.; Emberger, J.M.; Navarro, M., 1994:
CD23 antigen density is related to serum gamma globulin level, bone marrow reticulin pattern, and treatment in B chronic lymphocytic leukemia

Lecoanet-Henchoz, S.; Gauchat, J.F.; Aubry, J.P.; Graber, P.; Life, P.; Paul-Eugene, N.; Ferrua, B.; Corbi, A.L.; Dugas, B.; Plater-Zyberk, C., 1995:
CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18

Kaiserlian, D.; Lachaux, A.; Grosjean, I.; Graber, P.; Bonnefoy, J.Y., 1995:
CD23/FC epsilon RII is constitutively expressed on human intestinal epithelium, and upregulated in cow's milk protein intolerance

Beavil, R.L.; Graber, P.; Aubonney, N.; Bonnefoy, J.Y.; Gould, H.J., 1995:
CD23/Fc epsilon RII and its soluble fragments can form oligomers on the cell surface and in solution

Brown, G.R.; Meek, K.; Nishioka, Y.; Thiele, D.L., 1995:
CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+ T lymphocytes

Boise, L.H.; Minn, A.J.; Noel, P.J.; June, C.H.; Accavitti, M.A.; Lindsten, T.; Thompson, C.B., 1995 :
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL

Cerdan, C.; Martin, Y.; Courcoul, M.; Mawas, C.; Birg, F.; Olive, D., 1995:
CD28 costimulation up-regulates long-term IL-2R beta expression in human T cells through combined transcriptional and post-transcriptional regulation

Levine, B.L.; Ueda, Y.; Craighead, N.; Huang, M.L.; June, C.H., 1995:
CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro

Harding, F.A.; Allison, J.P., 1993:
CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help

Shinkai, Y.; Ma, A.; Cheng, H.L.; Alt, F.W., 1995:
CD3 epsilon and CD3 zeta cytoplasmic domains can independently generate signals for T cell development and function

Davey, M.P.; Starkebaum, G.; Loughran, T.P., 1995:
CD3+ leukemic large granular lymphocytes utilize diverse T-cell receptor V beta genes

Kojima, H.; Komeno, T.; Shinagawa, A.; Hasegawa, Y.; Kobayashi, T.; Ninomiya, H.; Nagasawa, T.; Abe, T., 1995:
CD3+, CD56+ large granular lymphocyte leukemia

Kern, F.; Ode-Hakim, S.; Nugel, H.; Volk, H.D.; Reinke, P., 1995:
CD3+/LFA-1 "bright" T cells represent memory-type effector cells, which, during immune activation in kidney graft recipients, are marked by increased cytokine mRNA levels

Kohanawa, M.; Nakane, A.; Asano, M.; Minagawa, T., 1995:
CD3+/TCR-alpha beta- cells are important in protecting spinal cord tissues against Theiler's virus strain GD VII infection

McDonald, P.P.; Cassatella, M.A.; Bald, A.; Maggi, E.; Romagnani, S.; Gruss, H.J.; Pizzolo, G., 1995:
CD30 ligation induces nuclear factor-kappa B activation in human T cell lines

Pizzolo, G.; Romagnani, S., 1995:
CD30 molecule (Ki-1 Ag): more than just a marker of CD30+ lymphoma

Paulli, M.; Berti, E.; Rosso, R.; Boveri, E.; Kindl, S.; Klersy, C.; Lazzarino, M.; Borroni, G.; Menestrina, F.; Santucci, M., 1995:
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group

Skubitz, K.M.; Goueli, S.A., 1994:
CD31 (PECAM-1), CDw32 (Fc gamma RII), and anti-HLA class I monoclonal antibodies recognize phosphotyrosine-containing proteins on the surface of human neutrophils

Piali, L.; Hammel, P.; Uherek, C.; Bachmann, F.; Gisler, R.H.; Dunon, D.; Imhof, B.A., 1995:
CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium

O'Kane-Murphy, B.; Jackson, J.D.; Kuszynski, C.; Costas, P.; Wang, P.N.; Warkentin, P.I.; Kessinger, A., 1994:
CD34 analysis in erythropoietin mobilized peripheral blood stem cells

Abenoza, P.; Lillemoe, T., 1993:
CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans

Cameselle-Teijeiro, J.; Varela-Durán, J., 1995:
CD34 and thyroid fibrous tumor

Sutherland, D.R.; Stewart, A.K.; Keating, A., 1993:
CD34 antigen: molecular features and potential clinical applications

Cacciola, E.; Guglielmo, P.; Cacciola, E.; Stagno, F.; Cacciola, R.R.; Impera, S., 1995:
CD34 expression in adult acute lymphoblastic leukemia

Sperling, C.; Büchner, T.; Sauerland, C.; Fonatsch, C.; Thiel, E.; Ludwig, W.D., 1993:
CD34 expression in de novo acute myeloid leukaemia

Cohen, P.R.; Rapini, R.P.; Farhood, A.I., 1995:
CD34 expression in neural and fibrohistiocytic lesions

Orazi, A., 1995:
CD34 immunoperoxidase staining for the diagnosis of myelodysplastic syndromes and chronic myeloid leukaemia

Oertel, J.; Huhn, D., 1994:
CD34 immunophenotyping of blasts in myelodysplasia

Zimmerman, T.M.; Lee, W.J.; Bender, J.G.; Mick, R.; Williams, S.F., 1994:
CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy

Bost, F.; Barnoud, R.; Peoc'h, M.; Le Marc'hadour, F.; Pasquier, D.; Pasquier, B., 1995:
CD34 positivity in solitary fibrous tumor of the liver

Hillyer, C.D.; Lackey, D.A.; Villinger, F.; Winton, E.F.; McClure, H.M.; Ansari, A.A., 1993:
CD34+ and CFU-GM progenitors are significantly decreased in SIVsmm9 infected rhesus macaques with minimal evidence of direct viral infection by polymerase chain reaction

Lanza, F.; Moretti, S.; Castagnari, B.; Latorraca, A.; Rigolin, G.M.; Bardi, A.; Castoldi, G., 1995:
CD34+ leukemic cells assessed by different CD34 monoclonal antibodies

Li, F.; Linton, G.F.; Sekhsaria, S.; Whiting-Theobald, N.; Katkin, J.P.; Gallin, J.I.; Malech, H.L., 1994:
CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease

Hillyer, C.D.; Lackey, D.A.; Hart, K.K.; Stempora, L.L.; Bray, R.A.; Bender, J.G.; Donnenberg, A.D., 1993:
CD34+ progenitors and colony-forming units-granulocyte macrophage are recruited during large-volume leukapheresis and concentrated by counterflow centrifugal elutriation

Rigolin, G.M.; Lanza, F.; Ferrari, L.; Castoldi, G., 1995:
CD34+/CD33+ blast cells: correlation with FAB subtypes

Miller, S.J., 1994:
CD34, stem cells, and the skin

Schmitt, C.; Ktorza, S.; Sarun, S.; Verpilleux, M.P.; Blanc, C.; Deugnier, M.A.; Dalloul, A.; Debré, P., 1995:
CD34-positive early stages of human T-cell differentiation

Jimenez, F.J.; Grichnik, J.M.; Clark, R.E., 1994:
CD34-positive spindle cells in nerves

Bean, A.G.; Godfrey, D.I.; Ferlin, W.G.; Santos-Argumedo, L.; Parkhouse, M.E.; Howard, M.C.; Zlotnik, A., 1995:
CD38 expression on mouse T cells: CD38 defines functionally distinct subsets of alpha beta TCR+CD4-CD8- thymocytes

Santos-Argumedo, L.; Lund, F.E.; Heath, A.W.; Solvason, N.; Wu, W.W.; Grimaldi, J.C.; Parkhouse, R.M.; Howard, M., 1995:
CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction

Thiounn, N.; Mathiot, C.; Flam, T.; Tartour, E.; Peyret, C.; Joyeux, I.; Abecassis, J.P.; Zerbib, M.; Fridman, W.H.; Debré, B., 1994:
CD4 TIL (Tumor Infiltrating Lymphocytes) induce complete response in patients treated with IL-2 (Interleukin-2). Preliminary study

Jack, A.S.; Richards, S., 1995 :
CD4 cell counts used as surrogate test for HIV infection

Phillips, A.N.; Pezzotti, P.; Lepri, A.C.; Rezza, G., 1994:
CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study

Moreno, A.; Clavijo, P.; Edelman, R.; Davis, J.; Sztein, M.; Sinigaglia, F.; Nardin, E., 1993:
CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein

Siliciano, R.F., 1993:
CD4+ T cell epitopes in HIV-1 proteins

Soriano, V.; Bravo, R.; Samaniego, J.G.; González, J.; Odriozola, P.M.; Arroyo, E.; Vicario, J.L.; Castro, A.; Colmenero, M.; Carballo, E., 1994:
CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C. HIV-Hepatitis Spanish Study Group

Tsukaguchi, K.; Balaji, K.N.; Boom, W.H., 1995:
CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production

Laurence, J., 1995:
CD4+ and CD8+ T lymphocyte activation in HIV infection. Implications for immune pathogenesis and therapy

Karmańska, K.; Houszka, M.; Miśta, D.; Stefaniak, E., 1994:
CD4+ and CD8+ cells in mice infected with Trichinella spiralis and treated with cyclosporine A

Curiel, T.J.; Wong, J.T.; Gorczyca, P.F.; Schooley, R.T.; Walker, B.D., 1993:
CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual

Pulido Ortega, F.; Carnevali-Ruiz, D.; Rubio García, R.; Costa Pérez-Herrero, J.R., 1994:
CD4+ lymphocytes and opportunistic infections and neoplasms in patients infected with the human immunodeficiency virus

Miró, J.M.; Buira, E.; Mallolas, J.; Gallart, T.; Moreno, A.; Zamora, L.; Vilella, R.; Gatell, J.M.; Soriano, E., 1994:
CD4+ lymphocytes and opportunistic infections and neoplasms in patients with human immunodeficiency virus infection

Altés, J.; Salas, A.; Riera, M.; Vilallonga, C., 1995:
CD4+ lymphocytes in patients with a Leishmania-HIV coinfection

Caminal Montero, L.; Ramos Barbón, D.; Ferro Mosquera, J.; Díaz López, J.B., 1995:
CD4+ lymphocytopenia and sarcoidosis

Imamura, N.; Abe, K.; Kuramoto, A., 1993:
CD4+, CD45RA+, CD29- T-cell lymphocytic leukemia functioning as T suppressor inducer for B-cell immunoglobulin synthesis

Heiligenhaus, A.; Berra, A.; Foster, C.S., 1994:
CD4+V beta 8+ T cells mediate herpes stromal keratitis

Klaus, S.J.; Berberich, I.; Shu, G.; Clark, E.A., 1994:
CD40 and its ligand in the regulation of humoral immunity

Carbone, A.; Gloghini, A.; Gruss, H.J.; Pinto, A., 1995:
CD40 antigen expression on Reed-Sternberg cells. A reliable diagnostic tool for Hodgkin's disease

O'Grady, J.T.; Stewart, S.; Lowrey, J.; Howie, S.E.; Krajewski, A.S., 1994:
CD40 expression in Hodgkin's disease

Hess, S.; Rensing-Ehl, A.; Schwabe, R.; Bufler, P.; Engelmann, H., 1995:
CD40 function in nonhematopoietic cells. Nuclear factor kappa B mobilization and induction of IL-6 production

Ramsdell, F.; Seaman, M.S.; Clifford, K.N.; Fanslow, W.C., 1994:
CD40 ligand acts as a costimulatory signal for neonatal thymic gamma delta T cells

Aversa, G.; Punnonen, J.; Carballido, J.M.; Cocks, B.G.; de Vries, J.E., 1994:
CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells

Gray, D.; Siepmann, K.; Wohlleben, G., 1994:
CD40 ligation in B cell activation, isotype switching and memory development

Armitage, R.J.; Maliszewski, C.R.; Alderson, M.R.; Grabstein, K.H.; Spriggs, M.K.; Fanslow, W.C., 1993:
CD40L: a multi-functional ligand

East, J.A.; Hart, I.R., 1993:
CD44 and its role in tumour progression and metastasis

Kincade, P.W.; He, Q.; Ishihara, K.; Miyake, K.; Lesley, J.; Hyman, R., 1993:
CD44 and other cell interaction molecules contributing to B lymphopoiesis

Haegel, H.; Dierich, A.; Ceredig, R., 1994:
CD44 in differentiated embryonic stem cells: surface expression and transcripts encoding multiple variants

Ponta, H.; Sleeman, J.; Dall, P.; Moll, J.; Sherman, L.; Herrlich, P., 1994:
CD44 isoforms in metastatic cancer

Friedrichs, K.; Kügler, G.; Franke, F.; Terpe, H.J.; Arlt, J.; Regidor, P.A.; Günthert, U., 1995:
CD44 isoforms in prognosis of breast cancer

Ishii, S.; Ford, R.; Thomas, P.; Nachman, A.; Steele, G.; Jessup, J.M., 1993:
CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen

Reinthaller, A.; Kainz, C.; Kohlberger, P.; Tempfer, C.; Gitsch, G.; Kölbl, H.; Breitenecker, G., 1995:
CD44 splice variants as prognostic factors in invasive cervix carcinoma

Koopman, G.; Griffioen, A.W.; Ponta, H.; Herrlich, P.; van den Berg, F.; Manten-Horst, E.; Pals, S.T., 1993:
CD44 splice variants; expression on lymphocytes and in neoplasia

Thomas, L., 1993:
CD44, the hyaluronic acid cell receptor. Its role in neoplastic invasion and metastatic dissemination

Favrot, M.C.; Combaret, V.; Lasset, C., 1993:
CD44--a new prognostic marker for neuroblastoma

Günthert, U., 1993:
CD44: a multitude of isoforms with diverse functions

Ilyas, M.; Abbasi, A.M.; Talbot, I.C.; Forbes, A., 1995:
CD44v6 and CD44v3 expression in ulcerative colitis and Crohn's disease

Geboes, K.; Rutgeerts, P., 1995:
CD44v6 and CD44v3 variants in inflammatory bowel disease

Waddick, K.G.; Uckun, F.M., 1993:
CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation

Chen, X.; Matsuura, Y.; Kearney, J.F., 1995:
CD5 transgenic mice

Lydyard, P.M.; Lamour, A.; MacKenzie, L.E.; Jamin, C.; Mageed, R.A.; Youinou, P., 1993:
CD5+ B cells and the immune system

Afeltra, A.; Paggi, A.; Ferri, G.M.; Amoroso, A.; Di Prima, M.A.; Startari, S.; Faralli, A.R.; Bonomo, L., 1993:
CD5+ B lymphocytes and CD4+ CD45RA+ T cells in Graves' disease

Sampalo, A.; López-Gómez, M.; Jiménez-Alonso, J.; Ortiz, F.; Samaniego, F.; Garrido, F., 1993:
CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease

Kearney, J.F., 1993:
CD5+ B-cell networks

Adami, F.; Semenzato, G.; Menestrina, F.; Chilosi, M., 1993:
CD5+ leukemic monocytoid B-cell lymphoma and lymphocytic lymphomas

Yu, J.R.; Qiu, Z.X.; Yang, H., 1994:
CD5+B cells and autoimmune diseases

Jones, B.M.; Lau, C.S.; Wong, R.W., 1994:
CD5-positive and CD5-negative plaque-forming cells against poly-L-lysine-treated sheep erythrocytes in patients with systemic lupus erythematosus

Wong, K.F.; Chan, J.K.; Ng, C.S., 1994:
CD56 (NCAM)-positive malignant lymphoma

Clark, D.A.; Vince, G.; Flanders, K.C.; Hirte, H.; Starkey, P., 1994:
CD56+ lymphoid cells in human first trimester pregnancy decidua as a source of novel transforming growth factor-beta 2-related immunosuppressive factors

Olweus, J.; Lund-Johansen, F.; Terstappen, L.W., 1995 :
CD64/Fc gamma RI is a granulo-monocytic lineage marker on CD34+ hematopoietic progenitor cells

Lauria, F.; Raspadori, D.; Ventura, M.A.; Rondelli, D.; Tura, S., 1994:
CD7 expression does not affect the prognosis in acute myeloid leukemia

Pillay, Y.; McLellan, G.; Davison, G.; Kelly, S.; Jacobs, P., 1995:
CD7 expression does not predict for poor outcome in acute myeloblastic leukemia

Del Poeta, G.; Stasi, R.; Venditti, A.; Masi, M.; Papa, G., 1993:
CD7 expression in acute myeloid leukemia

Ohe, K.; Okamura, T.; Arima, F.; Kamura, T.; Takamatsu, Y.; Murakawa, M.; Okamura, S.; Harada, M.; Niho, Y., 1994:
CD7 positive acute myelogenous leukemia exhibiting pleural involvement as an initial manifestation

Ochi, K.; Amano, M.; Soda, Y.; Togawa, A.; Takaku, F., 1994:
CD7 positive undifferenciated leukemia/lymphoma associated with leukemic pericarditis

Smith, M.R.; Mohamed, A.N.; Karanes, C., 1993:
CD7+ TdT+ chronic myelogenous leukemia blast crisis with null genotype

Katsuno, M.; Abe, Y.; Taguchi, F.; Yufu, Y.; Sadamura, S.; Goto, T.; Takatsuki, H.; Nishimura, J.; Hirata, J.; Akiyoshi, T., 1993:
CD7+ stem cell leukemia/lymphoma. Features of a subgroup without circulating blast cells

Yoshioka, K.; Terasaki, J., 1995:
CD7+, CD5+, CD4-, CD8-, and CD3- T-cell malignancy of the spleen after remission of invasive thymoma

Irie, H.Y.; Ravichandran, K.S.; Burakoff, S.J., 1995:
CD8 beta chain influences CD8 alpha chain-associated Lck kinase activity

Malbec, D.; Pinès, E.; Boudon, P.; Lusina, D.; Choudat, L., 1994:
CD8 hyperlymphocytosis syndrome and human immunodeficiency virus infection: 5 cases

Fossum, B.; Olsen, A.C.; Thorsby, E.; Gaudernack, G., 1995:
CD8+ T cells from a patient with colon carcinoma, specific for a mutant p21-Ras-derived peptide (Gly13-->Asp), are cytotoxic towards a carcinoma cell line harbouring the same mutation

Chang, J.C.; Smith, L.R.; Froning, K.J.; Schwabe, B.J.; Laxer, J.A.; Caralli, L.L.; Kurkland, H.H.; Karasek, M.A.; Wilkinson, D.I.; Carlo, D.J., 1995:
CD8+ T-cells in psoriatic lesions preferentially use T-cell receptors V beta 3 and/or V beta 13.1 genes

Conlon, K.; Lloyd, A.; Chattopadhyay, U.; Lukacs, N.; Kunkel, S.; Schall, T.; Taub, D.; Morimoto, C.; Osborne, J.; Oppenheim, J., 1995:
CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1 alpha, interleukin-8 and RANTES

Grohmann, U.; Bianchi, R.; Fioretti, M.C.; Fallarino, F.; Binaglia, L.; Uyttenhove, C.; Van Pel, A.; Boon, T.; Puccetti, P., 1995:
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide

Vadi, S.Kumar.; Mittal, B.Rai.; Gorla, A.Kumar.Reddy.; Sood, A.; Basher, R.Kumar.; Sood, A.; Kakkar, N.; Sen, R.K., 2017:
18F-FDG PET/CT in Diagnostic and Prognostic Evaluation of Patients With Suspected Recurrence of Chondrosarcoma

Echaniz, P.; Arrizabalaga, J.; Iribarren, J.A.; Cuadrado, E., 1993:
CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens

Mekada, E., 1995:
CD9 and the family of four transmembrane domain proteins

Crawford, P.R., 1995:
CDA = can't do-it alone

Anonymous, 1968:
CDA Auxiliary History

Anonymous, 1973:
CDA Caribbean Dental Program

Anonymous, 1972:
CDA Library helps dentists keep pace with change

Anonymous, 1971:
CDA acts on dentifrices, materials, devices; postpones grouping of specialties

Anonymous, 1970:
CDA adopts new by-lawa; revamps Board of Governors

Ma, G.; Li, J.; Xu, B.; Fu, L., 2018:
18F-FDG PET/CT in Primary Hepatic Neuroendocrine Tumors

Sigmon, J., 1971:
CDA appointed to ADA staff position

Johnson, E., 1973:
CDA assists in oral surgery performed under acupuncture anesthesia

Anonymous, 1969:
CDA charts new course; revamps Board of Governors

Anonymous, 1984:
CDA committee report: applicants to Canadian dental schools 1982-1983. Who are they? What are they like? Canadian Dental Association

Anonymous, 1974 :
CDA members

Anonymous, 1966:
CDA protests Canada-medicare discrimination against dentists

Anonymous, 1982:
CDA speaks for Canadian dentists

Hewitt, P.E.; Win, A.A.; Davies, S.C., 1984:
CDA type I with persistent haemosiderinuria: absence of iron loading

Anonymous, 1974:
CDA up-dates fluoridation statistics

Cooper, C., 1981:
CDA's answer to the busyness problem

Silverstein, S.J.; Larson, S.; Eckhaus, B., 1980:
CDA's model dental health kit: does it work in classrooms?

Harrop, D.E., 1994:
CDAC prepares for implementation

Manian, F.A.; Meyer, L., 1995:
CDAD rates

Anonymous, 1995:
CDC Clearinghouse offers new HIV-AIDS Treatment Information Service

Friede, A.; Rosen, D.H.; Reid, J.A., 1994:
CDC WONDER: a cooperative processing architecture for public health

Anonymous, 1995:
CDC advocates routine counseling and voluntary testing for HIV in all pregnant women

Cotton, D.; Higgins, D.; Person, B.; Darrow, W., 1994:
CDC behavioral interventions

Adachi, N., 1982:
CDC guideline recommendation questioned

Anonymous, 1983:
CDC guidelines for the prevention and control of nosocomial infections

Simmons, B.P., 1983:
CDC guidelines for the prevention and control of nosocomial infections. Guideline for hospital environmental control

Williams, W.W., 1984:
CDC guidelines for the prevention and control of nosocomial infections. Guideline for infection control in hospital personnel

Simmons, B.P., 1983:
CDC guidelines for the prevention and control of nosocomial infections. Guideline for prevention of intravascular infections

Tice, B., 1982:
CDC guidelines on sterilization of implants

Anonymous, 1995:
CDC issues TB guidelines

Anonymous, 1995:
CDC issues new infection control guidelines

Anonymous, 1995:
CDC issues recommendations for preventing spread of vancomycin resistance

Balows, A.; Printz, D.W., 1972:
CDC program for diagnosis of gonorrhea

Anonymous, 1995:
CDC publishes report on chorionic villus sampling and amniocentesis

Garner, J.S.; Williams, W.W.; Hughes, J.M., 1984:
CDC recommendation clarified

McCarthy, M., 1995:
CDC recommends wider prenatal HIV screening

Anonymous, 1995:
CDC releases draft guidelines on prevention of neonatal group B streptococcal disease

Anonymous, 1995:
CDC releases update on influenza activity and on composition of 1995-96 influenza vaccine

Anonymous, 1994:
CDC report on teen smoking

Anonymous, 1995:
CDC responds to media reports that Florida dentist not source of HIV infection for six patients

Anonymous, 1995:
CDC says NC workers get little legal protection from smoke

Anonymous, 1982:
CDC sets probe of Kaposi's in homosexuals

Crow, S., 1982:
CDC's guidelines on infection control; more guidelines

Kokko, U.P., 1970:
CDC's position on in vitro antimicrobial susceptibility testing

Smith, J.C., 1981:
CDC's surveillance of surgical sterilization: objectives and methods of data collection

Anonymous, 1995:
CDC: provide HIV counseling and voluntary testing to all pregnant women

Asamoto, H.; Hisa, T.; Sawano, T.; Sakai, K.; Kitamura, S.; Matsushita, N.; Kokura, M.; Satake, H.; Kawakami, I., 1984:
CDDP-containing combination chemotherapy for advanced lung cancer

Mein, S., 1983:
CDH--a mother's experience

Hopf, A.; Eysel, P.; Dubousset, J., 1995:
CDH: preliminary report on a new anterior spinal instrumentation

Kline, C.; Sipko, K., 1974:
CDHA manpower and utilization survey results

Bagley, J.L., 1980:
CDL program not doing the job--yet

Dewey, G.S., 1995:
CDM/CONDAM. The Construction (Design and Management) Regulations 1994

Corso, E.A.; Arena, M.; Ventimiglia, A.; Bizzarro, G.; Campo, G.; Rodolico, F., 1982:
CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology

Hashihira, S.; Nishii, T.; Mori, R.; Takeda, Y.; Tai, J., 1974:
CDP-choline as a drug for pancreatitis

Lachant, N.A.; Tanaka, K.R., 1984:
CDP-choline does not inhibit erythrocyte glycolytic or pentose phosphate pathway enzyme activity

Seminara, S.; Galluzzi, F.; Salti, R.; Chiccoli, A.; Nania, C.; La Cauza, C., 1982:
CDP-choline in the study of somatotropin function in childhood

Possmayer, F., 1974:
CDP-choline reversal of the CMP and CTP inhibition of phosphatidic acid synthesis by rat brain preparations

Romero, A.; Grau, T.; Sacristán, A.; Ortiz, J.A., 1983:
CDP-choline: 6-month study on toxicity in dogs

Grau, T.; Romero, A.; Sacristán, A.; Ortiz, J.A., 1983:
CDP-choline: acute toxicity study

Sánchez, M.C.; Fernández, J.M.; Forné, E.; Castelló, J.; Sacristán, A.; Ortíz, J.A., 1983:
CDP-choline: physico-chemical characteristics

Dinsdale, J.R.; Griffiths, G.K.; Castelló, J.; Maddock, J.; Ortiz, J.A.; Aylward, M., 1983:
CDP-choline: repeated oral dose tolerance studies in adult healthy volunteers

Dhainaut, J.F.; Vincent, J.L.; Richard, C.; Lejeune, P.; Martin, C.; Fierobe, L.; Stephens, S.; Ney, U.M.; Sopwith, M., 1995:
CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group

Horrocks, L.A.; Dorman, R.V.; Dabrowiecki, Z.; Goracci, G.; Porcellati, G., 1981:
CDPcholine and CDPethanolamine prevent the release of free fatty acids during brain ischemia

Anonymous, 1994:
CDR and GPV technical briefings at WHO headquarters

Boullier, S.; Cochet, M.; Poccia, F.; Gougeon, M.L., 1995:
CDR3-independent gamma delta V delta 1+ T cell expansion in the peripheral blood of HIV-infected persons

Anonymous, 1971:
CDS methods of payment

Garron, M.; Bare, D.M.; Williams, E.L., 1970:
CDS prepaid dentistry and the dentist: an answer to Dr. Bare and Dr. Williams

Smith, C., 1995:
CDS survey shows 90% of local dentists offer pro bono care

Strauss, D., 1983:
CDS-AG medium for red blood cell preservation

Anonymous, 1984:
CDT today: an overview of the practical tests

Anonymous, 1984:
CDT today: complete dentures specialty examination

Anonymous, 1984:
CDT today: crown and bridge specialty examination

Anonymous, 1984:
CDT today: partial dentures specialty examination

Anonymous, 1984:
CDT today: the ceramics specialty examination

Anonymous, 1984:
CDT today: the inside story

Anonymous, 1972:
CDU concepts on public health policy

Meyers, R., 1984:
CE by appointment: meeting continuing education needs and cost containment

Anonymous, 1983:
CE credit through home study. Confusion: recognition and remedy

Ross, V.; Robinson, B., 1984:
CE credit through home study. Dizziness: causes, prevention, and management

Wolff, E.M., 1984:
CE evaluation. An approach to a self-study

Hicks, D.J.; Sprague, B.S.; Roe, S.C., 1982:
CE footprints on Arizona highways

Edgil, A.E., 1981:
CE for the educator role of nursing faculty

MacFadyen, J.S., 1983:
CE needs: American nurses working overseas

Donley, R., 1974:
CE or not CE? (Is it really a question?)

Anonymous, 1980:
CE roundup

Anonymous, 1980:
CE roundup: mandatory CE. The status today

Villani, C., 1981:
CEA (carcinoembryonic antigen) in breast cancer. Clinical value

Anonymous, 1981:
CEA (carcinoembryonic antigen): its role as a marker in the management of cancer

Dalla Palma, P.; Parenti, A.; Poletti, A., 1984:
CEA and ABO(H) in upper urinary tract transitional tumors

Nap, M.; Keuning, H.; Burtin, P.; Oosterhuis, J.W.; Fleuren, G., 1984:
CEA and NCA in benign and malignant breast tumors

Iannucci, F.; di Matteo, L.; Di Martino, G.; Tranchese, D.; Auriemma, L.; Micillo, E.; Catena, E., 1983:
CEA and TPA in serum and pleural exudates in patients with pulmonary neoplasms: preliminary results

Krush, A.J.; Zamcheck, N.; Lynch, H.T., 1983:
CEA and genetics. Gardner's syndrome

Mor, C.; Moro, E.; Accinni, R.; Bartorelli, A.; Secchi, A.; Orefice, S., 1980:
CEA and immunosuppression: investigation performed on patients with gastrointestinal advanced adenocarcinomas treated with immunochemotherapy

Nagasue, N., 1983:
CEA and liver regeneration following hepatectomy

Pravettoni, G.; Parisi, M.; Benedetti, U., 1980:
CEA and protein determination in the acute phase in assessing the degree of malignancy of gastrointestinal tract tumors

Matsuoka, Y., 1983:
CEA and related antigens as possible new tumor markers

Anonymous, 1980:
CEA as a cancer marker

Anonymous, 1981:
CEA as a cancer marker sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, Office of the Director, NIH

Melica, A.; Contaldo, V.; Costanzo, R.; De Carlo, R.; De Mitri, A.; Donateo, L.; Gerardi, R.; Peluso, P.; Pezzuto, R., 1982:
CEA as a marker in primary and secondary pulmonary tumors

Kato, K.; Morimoto, T.; Kato, T.; Yasue, M.; Takagi, H.; Kito, T.; Nakazato, H.; Miyaishi, S.; Yamada, E.; Kuwabara, M.; Suchi, T., 1980:
CEA assays in postoperative detection of recurrent colorectal carcinoma

Farini, R.; Nitti, D.; Del Favero, G.; Rossi, C.R.; Costantin, G.; Rebuffi, A.; Farini, A.; Piccoli, A.; Matarazzo, R.; Lise, M.; Naccarato, R., 1980:
CEA concentration and cytology in duodenal fluid collected during the Secretin-Pancreozymin test. Attempt at an early diagnosis of pancreatic carcinoma by means of simple procedure

Schmitt, F.C., 1994:
CEA content in breast lesions

Dilawari, J.B.; Lennard-Jones, J.E., 1974:
CEA estimation in ulcerative colitis with and without malignant change

Alabiso, O.; Cena, E.; Martorana, L.; Zanini, M.; Bellizzi, A.; Rossi, A., 1985:
CEA in the follow-up of breast carcinoma

Mistretta, A.P.; Bartorelli, A.; Golferini, A.; Tassi, G.C.; De Barbieri, A.; Accinni, R., 1973:
CEA isolation from hepatic metastases of primary colon adenocarcinoma and preparation of specific antiserum

Turrin, A.; Ringhini, R.; de Palo, G.M.; Spinelli, P.; Bombardieri, E.; Buraggi, G.L., 1980:
CEA level in peritoneal lavage fluid

Bivins, B.A.; Meeker, W.R.; Griffen, W.O., 1974:
CEA levels and prognosis in colon carcinoma

Horn, Y.; Walach, N.; Zeidman, J.L.; Sharf, S., 1982:
CEA levels in active and non-active malignant tumors

Aoki, M.; Takeuchi, J.; Handa, H., 1983:
CEA like substance in cystic fluid of craniopharyngioma

Steele, G.; Ellenberg, S.; Ramming, K.; O'Connell, M.; Moertel, C.; Lessner, H.; Bruckner, H.; Horton, J.; Schein, P.; Zamcheck, N.; Novak, J.; Holyoke, E.D., 1982:
CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols

Hörst, M.; Wiest, W., 1982:
CEA monitoring of gynecologic tumor patients using a simplified CEA-radioimmunoassay

von Kleist, S.; Wittekind, C.; Sandritter, W.; Gropp, H., 1982:
CEA positivity in sera and breast tumor tissues obtained from the same patients

Wittekind, C.; Von Kleist, S.; Sandritter, W., 1981:
CEA positivity in tissue and sera of patients with benign breast lesions

Huyghe, J., 1983:
CEA radioimmunoassay. Clinical applications in colorectal cancer

Satler, J.J.; Herzog, B., 1982:
CEA serum values controversy

Cuthbertson, A.M.; Hughes, E.S.; Nairn, R.C.; Nind, A.P.; Pihl, E., 1981:
CEA testing in colorectal cancer

Nagel, R.; Borgmann, V.; Kemper, J.D., 1981:
CEA, HCG-beta and alpha fetoproteins - clinical significance as tumor markers

O'Brien, M.J.; Kirkham, S.E.; Burke, B.; Ormerod, M.; Saravis, C.A.; Gottlieb, L.S.; Neville, A.M.; Zamcheck, N., 1980:
CEA, ZGM and EMA localization in cells of pleural and peritoneal effusion: a preliminary study

Sironi, M.; Cantaboni, A., 1984:
CEA, grade and stage in breast carcinoma. Immunohistochemical study of 40 cases

O'Brien, P.H., 1980:
CEA--a concept worth exploring

Urdl, W.; Pickel, H.; Pürstner, P.; Schrödl, P., 1980:
CEA--a parameter in the course of chemotherapy of ovarian cancer

Metzger, U.; Bronz, K.; Siebenmann, R.; Seefeld, U.; Bühler, H.; Largiadèr, F., 1984:
CEA-controlled indications for re-operation in cancer of the large intestine

Rogers, G.T.; Keep, P.A., 1980:
CEA-like activity in normal colon tissue

Duffy, M.J.; O'Connell, M.; O'Sullivan, F.; McKenna, B.; Allen, M.A.; McDonnell, L., 1983:
CEA-like material in cytosols from human breast carcinomas. Correlation with biochemical and pathologic parameters

Fleisher, M.; Oettgen, H.F.; Breed, C.N.; Robbins, G.F.; Pinsky, C.M.; Schwartz, M.K., 1974:
CEA-like material in fluid from benign cysts of the breast

Koness, R.J., 1995:
CEA: is it of value in colorectal cancer?

Rinke, C., 1980:
CEA: still trying to find a niche

Munchrath, M., 1984:
CEARP - why bother?

Judy, M.G., 1983:
CEARP applications: critical criteria

Jain, A.; Jain, S.; Khatri, P.C.; Miglani, N., 1980:
CEBS: a method for the rapid assessment of gestational age

Geer, W.C.; Deno, E.D., 1965:
CEC and legislation--now and in the future

Jordan, J.B., 1968:
CEC-ERIC-IMC: a program partnership in information dissemination

Abrams, G.D., 1983:
CEHM: Ninth Conference--keynote address

Carrow-Woolfolk, E., 1983:
CELI validity reviewed: a response to McDade, Simpson, and Lamb (1982)

Wallinder, I.B.; Neujahr, H.Y., 1971:

Donaghey, C.E., 1980:
CELLSIM: cell cycle simulation made easy

Kaleta, E.F., 1969:
CELO virus in gosslings

Greuel, E., 1966:
CELO virus infection

Ahmed, A.A., 1971:
CELO virus infection in turkeys

Mancini, L.O.; Yates, V.J.; Anderson, J.; Jasty, V., 1970:
CELO virus: an oncogenic virus. Brief report

O'Brien, J.J., 1982:
CEM (contagious equine metritis) in Northern Ireland

Sahu, S.P., 1980:
CEM bacteria

Swerczek, T.W., 1980:
CEM in horses: assuring diagnostic precision

Bryant, K.K., 1995:
CEN review questions. Thyroid storm

Neiman, J.S., 1982:
CEO sets the style of organization's planning

Corley, B.; Crawford, M.; Norling, R.; Burgin, B.; Ackerman, F.K.; Wallace, S., 1995:
CEO summit--the leadership perspective. Roundtable discussion, Part 2

Corley, B.; Crawford, M.; Norling, R.; Burgin, B.; Ackerman, F.K.; Wallace, S., 1995:
CEO summit. The leadership experience--roundtable discussion

Regan, W.A., 1980:
CEO-board contract should cover special services

DeVries, R.A., 1980:
CEOs don educator's cap

Thomas, K.A.; Cook, S.D.; Westfall, R.L., 1984:
CEPHS--a system for computer analysis of cephalometric radiographs

Lyon, D.O., 1967:
CER methodology: reply to Blackman

Williams, J.G.; Eston, R.; Furlong, B., 1994:
CERT: a perceived exertion scale for young children

Wallace, V.; Lacthem, S., 1995:
CESDI: data collection

Alles, P., 1995:
CESF Medical Outcomes Research Project: implementing outcomes assessment in a clinical setting

Inazu, A.; Koizumi, J.; Mabuchi, H., 1994:
CETP deficiency

Humbrecht, B.; Van Parys, E., 1982:
CEU feature article. From assessment to interventional: how to use heart and breath sounds as part of your nursing care plan

George, G., 1982:
CEU feature article: if patient teaching tries your patience, try this plan

Keithley, J.K.; Fraulini, K.E., 1982:
CEU offering. What's behind that I.V. line?

Dake, M.A., 1974:
CEU- a means to an end?

Favilla, D.K., 1981:
CEUs are confining

Ezquieta, B.; Molano, J., 1993:
CF2603/4delT, a new frameshift mutation in exon 13 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene

Hodges, D.M., 1972:
CFB Petawawa primary schools brush-in

Zwetnow, N., 1968:
CFB autoregulation to blood pressure and intracranial pressure variations

Dunn, W.J.; Albert, G.; Zarb, G., 1969:
CFDE What has it done for dentistry

Anonymous, 1967:
CFDE: a national responsibility

Ogiński, A.; Koźlakowska-Swigoń, L.; Pokorski, J.; Iskra-Golec, I., 1981:
CFF as an index of stress of operators of control desks working in constant motion

Kerr, T.A., 1995:
CFPC alternate funding model

Williams, A.C.; Levine, R.A.; Chase, T.N.; Lovenberg, W.; Calne, D.B., 1980:
CFS hydroxylase cofactor levels in some neurological diseases

Cerrato, D.; Salmaggi, A.; Ariano, C.; La Mantia, L.; Nespolo, A., 1984:
CFS oligoclonal bands in MS and other neurological diseases detected by agarose isoelectric focusing and electrophoresis

Merelli, E.; Sola, P.; Faglioni, P.; Pavarotti, V., 1982:
CFS transferrin in various neurological diseases

Smirnova, V.N.; Eubova, E.F.; Izotova, N.V., 1966:
CFT with viruses of the Coxsackie A group and methods of preparing the antigens

Dupuit, F.; Kälin, N.; Brézillon, S.; Hinnrasky, J.; Tümmler, B.; Puchelle, E., 1995:
CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium

Cozens, A.L.; Yezzi, M.J.; Kunzelmann, K.; Ohrui, T.; Chin, L.; Eng, K.; Finkbeiner, W.E.; Widdicombe, J.H.; Gruenert, D.C., 1994:
CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells

Chinet, T., 1995:
CFTR protein and molecular mechanisms of pulmonary involvement in cystic fibrosis

Musashi, M.; Kawamura, K., 1982:
CFU-C and hematopoietic disorders

Morris, T.C.; Vincent, P.C.; Young, G.A.; Sutherland, R.; Forrest, P.R.; Isbister, J.P., 1984:
CFU-C inhibitors in aplastic anaemia

Adams, J.A.; Barrett, A.J.; Kendra, J.R., 1982:
CFU-C proliferation and granulopoiesis in suspension cultures of bone marrow, cord blood and adult blood

Gordon, M.Y.; Coggle, J.E., 1974:
CFU-C yields from the haemopoietic tissues of normal and leukaemic RFM mice

Sawada, K.; Sakurama, T., 1982:
CFU-E and hematopoietic disorders

Marcus, R.E.; Knott, L.J., 1984:
CFU-GM and T cell subsets in young red cell collections

Kaspar, L.V.; Seed, T.M., 1984:
CFU-GM colony-enhancing activity in sera of dogs under acute and chronic gamma-irradiation regimens

Guigon, M.; Dumenil, D.; Enouf, J.; Frindel, E., 1981:
CFU-S differentiation after multiple doses of cytosine arabinoside-effect of inhibitors

Georgiou, G.M.; Roberton, D.M.; Ellis, W.M.; Shen, B.J.; Ekert, H.; Hosking, C.S., 1983:
CFU-c enrichment from human bone marrow using a discontinuous Percoll gradient and soybean agglutinin in comparison with Ficoll-paque

Pessina, A.; Brambilla, P.; Villa, S.; Mocarelli, P., 1982:
CFU-s and CFU-c proliferation after treatment of normal bone marrow cells with Ehrlich ascitic fluid

Francis, G.E.; Wing, M.A.; Berney, J.J.; Guimaraes, J.E., 1983:
CFUGEMM, CFUGM, CFUMK: analysis by equilibrium density centrifugation

Hagan, M.P.; MacVittie, T.J., 1981 :
CFUs kinetics observed in vivo by bromodeoxyuridine and near-UV light treatment

Starostin, V.I.; Sokolova, E.A.; Turdyev, A.A., 1984:
CFUs of the normal and regenerating liver in the sexually mature mouse

Fedorov, N.A.; Koreshkova, N.A.; Stepanova, S.B.; Guliaev, N.N., 1980:
CFUs proliferative responses to exogenous soluble and immobilized cyclic nucleotides

Poljak-Blazi, M.; Slijepcević, M.; Boranić, M., 1980:
CFUs reduction and adaptation in mice with experimental diabetes

Anonymous, 1980:
CFY supervisors' responsibilities

Pradhan, S.; Houlston, C.; Cummings, M.; Adams, R.L., 1995:
CG and CNG methyltransferases in plants

Tykocinski, M.L.; Max, E.E., 1984:
CG dinucleotide clusters in MHC genes and in 5' demethylated genes

Poncet, D.; Verdier, G.; Nigon, V.M., 1983:
CG sites and their nucleotide environment in the human gamma-delta-beta-globin gene cluster: distribution, frequency and possible frame for differential methylation

Ishigami, J.; Hara, S.; Shiba, T., 1968:
CG-201, a new antispasmodic, in urological practice

Maliarchuk, B.A., 1995:
CG-methylation and mutagenesis of human mitochondrial DNA

Vaidya, P.R.; Purandare, B.N.; Rao, S.S.; Raghavan, V., 1973 :
CGH titres in clomiphene induced pregnancies

Waldmeier, P.C.; Tipton, K.F.; Bernasconi, R.; Felner, A.E.; Baumann, P.A.; Maitre, L., 1984:
CGP 4718 A, a new potential antidepressant with a dual mode of action

Staehelin, M.; Simons, P.; Jaeggi, K.; Wigger, N., 1983:
CGP-12177. A hydrophilic beta-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells

Anonymous, 1994:
CGPCSD survey results. Council of Graduate Programs in Communication Sciences and Disorders

Jacot des Combes, B.; Turini, G.A.; Brunner, H.R.; Porchet, M.; Chen, D.S.; Sen, S., 1983:
CGS 13945: a new orally active angiotensin-converting enzyme inhibitor in normal volunteers

Liebman, J.M.; Lovell, R.A.; Braunwalder, A.; Stone, G.; Bernard, P.; Barbaz, B.; Welch, J.; Kim, H.S.; Wasley, J.W.; Robson, R.D., 1983:
CGS 7525A, a new, centrally active alpha 2 adrenoceptor antagonist

Rodgers, R.J.; Clemmitt, M., 1984:
CGS 8216 fails to modify novelty-related behaviour in mice: further evidence for differential actions of benzodiazepine antagonists

Schwarz, M.; Turski, L.; Sontag, K.H., 1984:
CGS 8216, Ro 15-1788 and methyl-beta-carboline-3-carboxylate, but not EMD 41717 antagonize the muscle relaxant effect of diazepam in genetically spastic rats

Czernik, A.J.; Petrack, B.; Kalinsky, H.J.; Psychoyos, S.; Cash, W.D.; Tsai, C.; Rinehart, R.K.; Granat, F.R.; Lovell, R.A.; Brundish, D.E.; Wade, R., 1982:
CGS 8216: receptor binding characteristics of a potent benzodiazepine antagonist

Shannon, H.E.; Davis, S.L., 1984:
CGS8216 noncompetitively antagonizes the discriminative effects of diazepam in rats

Bruch Igartúa, E.M.; Lafage, M.R.; Domecq, P.; Findor, J.A.; Domecq, R.B., 1980:
CGT/ALAT index in jaundice

Hurwitz, J.L.; Coleclough, C.; Cebra, J.J., 1980:
CH gene rearrangements in IgM-bearing B cells and in the normal splenic DNA component of hybridomas making different isotypes of antibody

Cebra, J.J.; Komisar, J.L.; Schweitzer, P.A., 1984:
CH isotype 'switching' during normal B-lymphocyte development

Morita, K., 1974:
CH stretching vibrational spectra of sugar acetates

Morita, K., 1974:
CH stretching vibrational spectra of sugar derivatives. II. CH stretching vibrational spectra of alkyl glycosides

Iliadi-Alexandrou, M.E.; Patramani, I.; Venetsanos, P.; Parissis, N.; Pavlatou, M., 1982:
CH50 and C3 component of complement in Hansen's disease

Anonymous, 1970:
CHA board of trustees statement of principles on the integration of medical staff activities into the management of the total hospital operation

Hiltz, G.M., 1974:
CHA chairman's address

Brosseau, B.L., 1974:
CHA must stay in health education

Anonymous, 1969:
CHA personal members

LeTouzé, D., 1984:
CHA proposes national hospital of the future forum

Hurley, P., 1984:
CHA's Telidon project: a progress report

Macaluso, D.; Stein, B.; Polster, L.R., 1980:
CHAMP: a comparative study approach

Carter, A.M.; van Vleet, M.A., 1995:
CHAMPUS psychiatric inpatient savings: military management versus contractor, the Fort Polk experience

Baughman, F.A., 1971:
CHANDS: the curly hair-ankyloblepharon-nail dysplasia syndrome

Pagon, R.A.; Zonana, J.; Graham, J.M., 1982:
CHARGE association

North, K.N.; Wu, B.L.; Cao, B.N.; Whiteman, D.A.; Korf, B.R., 1995:
CHARGE association in a child with de novo inverted duplication (14)(q22-->q24.3)

Rowden, R., 1981:
CHCs are here to stay

Brown, A., 1981:
CHCs: less bark and no bite?

Mencík, M., 1982:
CHD risk factors in research personnel and university staff

Whyman, C., 1994:
CHICA-Canada position statement on infection prevention and control programs

Hashimoto, K.; Topper, S.; Sharata, H.; Edwards, M., 1995:
CHILD syndrome: analysis of abnormal keratinization and ultrastructure

Moulin, G.; Barrut, D.; Franc, M.P.; Fauchet, R., 1982:
CHILD. syndrome. Epidermal nevus and homolateral hypoplastic body hemidysplasia

Anonymous, 1974:
CHIP: the administration's comprehensive health insurance plan

Vose, J.M., 1995:
CHLVPP therapy for Hodgkin's disease identification of prognostic factors

Cheung, E.; Juliano, R.L., 1984:
CHO cell aggregation induced by fibronectin-coated beads. Differences between wild-type and adhesion-variant cells

Hunt, L.A., 1980:
CHO cells selected for phytohemagglutinin and con A resistance are defective in both early and late stages of protein glycosylation

Cabral, F.; Sobel, M.E.; Gottesman, M.M., 1980:
CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered beta-tubulin

Hama-Inaba, H.; Shimazu, Y.; Takusagawa, M.; Sato, K.; Morimyo, M., 1994:
CHO.K1 cell mutants sensitive to active oxygen-generating agents. I. Isolation and genetic studies

McLaughlin, P.; Cabanillas, F.; Hagemeister, F.B.; Swan, F.; Romaguera, J.E.; Taylor, S.; Rodriguez, M.A.; Velasquez, W.S.; Redman, J.R.; Gutterman, J.U., 1993:
CHOP-Bleo plus interferon for stage IV low-grade lymphoma

Schneider, T.; Molnár, Z.; Várady, E.; Ringwald, G.; Fleischmann, T., 1994:
CHOP-Bleo therapy in high-malignancy non-Hodgkin lymphoma

Kahn, C.E., 1995:
CHORUS: a computer-based radiology handbook for international collaboration via the World Wide Web

Ardell, D.B., 1974:
CHP and multifunctional regional councils: a reappraisal

Foster, C.T., 1973:
CHP, HPC, DHSA, ADH stirring the alphabet soup

Dabney, W.M., 1974:
CHP: a three-letter word and a medical imperative

Balás, E.A.; Váraljai, T.; Juhász, I., 1982:
CHRONOS-H: a general computer-assisted follow-up system

Maurita, M., 1971:
CHSLP: expectations and realizable goals

Sanou, A.; Traoré, S.S.; Sano, D.; Dakoure, R.; Compaoré, T.; Yago, Z., 1994:
CHolelithiasis in Burkina Faso (apropos of 44 cases operated on at NHC YO

Crecchia, C.; Marullo-Reedtz, G.; Bram, S., 1969:
CI-581 and electroconvulsive therapy

Nishimura, N.; Mendori, S.; Dento, I., 1969:
CI-581 for general anesthesia: clinical experience

Spoerel, W.E.; Kandel, P.F., 1970:
CI-581 in anaesthesia for tonsillectomies in children

Nalda Felipe, M.A.; Aguado Matorras, A., 1970:
CI-581 in neuroradiology

Del Prete, S.; Margaria, E.; Bosio, U., 1968:
CI-581 in pediatric surgery

Ginsberg, H.; Gerber, J.A., 1968:
CI-581: a clinical report on 100 patients

Villeneuve, C.; Ananth, J.V.; Ban, T.A.; Lehmann, H.E., 1970:
CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients

Weaver, S.S.; Bodey, G.P., 1980:
CI-867, a new semisynthetic penicillin: in vitro studies

Kaplan, H.R.; Cohen, D.M.; Essenburg, A.D.; Major, T.C.; Mertz, T.E.; Ryan, M.J., 1984:
CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors

Kojima, T.; Une, I.; Yashiki, M., 1983:
CI-mass fragmentographic analysis of methamphetamine and amphetamine in human autopsy tissues after acute methamphetamine poisoning

Kradolfer, F.; Sackmann, W.; Zak, O.; Brunner, H.; Hess, R.; Konopka, E.A.; Gelzer, J., 1970:
CIBA 36278-Ba" chemotherapy and toxicology in laboratory animals

de Bold, A.J., 1995:
CIBA Award for Hypertension Research. 1994

McLaren, A.; Parkes, A.S., 1973:
CIBA foundation symposium. Legal and other aspects of artificial insemination by donor (AID) and embryo transfer

Davis, F., 1974:
CIBA's commitment--the high blood pressure revolution

Anonymous, 1970:
CIBA. Keeping pace along a broad front

Murray, C.B.; Morales, M.M.; Flotte, T.R.; McGrath-Morrow, S.A.; Guggino, W.B.; Zeitlin, P.L., 1995:
CIC-2: a developmentally dependent chloride channel expressed in the fetal lung and downregulated after birth

Anonymous, 1982:
CICIAMS XII World Congress

Anonymous, 1981:
CICIAMS' survey on primary health care. Report of the International Technical Committee

Anonymous, 1974:
CICR; 25th anniversary of the Geneva Conventions

Steen, J., 1972:
CIDA medical assistance program. Canadian International Development Agency

Lévesque-Boudreau, D., 1995:
CII and CMDP: reflecting the professional relations between nurses and physicians. Interview by Suzanne Blanchet

Karag'ozov, I., 1984:
CIN (cervical intraepithelial neoplasia) in women under 25

Dietl, J.; Semm, K.; Hedderich, J.; Buchholz, F., 1983:
CIN and preclinical cervical carcinoma. A study of morbidity trends over a 10-year period

Giacomini, G.; Simi, U., 1983:
CIN or not CIN

Fenoglio, C.M., 1984:
CIN or not to sin

Reed, W.C., 1995:
CIOs and the D.R.I.P. (data-rich, information-poor) syndrome

Eberle, D.O.; Suter, R.; Nowak, K.; Bosshardt, H.P., 1974:
CIPAC collaborative study of the heat-stability of Diazinon formulations, using both CIPAC and AOAC analytical methods

Tanaka, J.; Shimizu, R.; Hatano, M., 1970:
CIR (cell injuring reaction) active substances in culture fluid of Bacillus cereus "MS-1063 strain"

Korzh, A.A.; Revenko, T.A.; Shumada, I.V., 1971:
CITO and the development of traumatology and orthopedics in the Ukraine

Sivash, K.M.; Borodkin, V.S.; Kozhin, N.P., 1973:
CITO longitudinal frame for orthopedic bed

Weber, H.; Khorana, H.G., 1972:
CIV. Total synthesis of the structural gene for an alanine transfer ribonucleic acid from yeast. Chemical synthesis of an icosadeoxynucleotide corresponding to the nucleotide sequence 21 to 40

Agarwal, K.L.; Kumar, A.; Khorana, H.G., 1972:
CIX. Total synthesis of the structural gene for an alanine transfer ribonucleic acid from yeast. Synthesis of a dodecadeoxynucleotide and a decadeoxynucleotide corresponding to the nucleotide sequence 46 to 65

Sakemi, S.; Inagaki, T.; Kaneda, K.; Hirai, H.; Iwata, E.; Sakakibara, T.; Yamauchi, Y.; Norcia, M.; Wondrack, L.M.; Sutcliffe, J.A., 1995:
CJ-12,371 and CJ-12,372, two novel DNA gyrase inhibitors. Fermentation,isolation, structural elucidation and biological activities

Kettunen, P.; Kala, R.; Rehunen, S., 1984:
CK and CK-MB in skeletal muscle of athletes and in serum after thoracic contusion in sport

Habel, F., 1980:
CK concentration--an indicator of infarct size?

Kettunen, P., 1983:
CK isoenzymes and transaminases after coronary cardiography, cardiac surgery and non-cardiac thoracotomy

Bendz, R.; Ström, S.; Olin, C., 1980:
CK-MB in serum and in heart and skeletal muscles in patients subjected to mitral valve replacement

Alia, J.M., 1980:
CK-MB in some pediatric patients

Tsung, S.H.; Huang, T.Y.; Lin, J.I., 1982:
CK-MB isoenzyme in patients with polymyositis

Lee, M.E.; Sethna, D.H.; Conklin, C.M.; Shell, W.E.; Matloff, J.M.; Gray, R.J., 1983:
CK-MB release following coronary artery bypass grafting in the absence of myocardial infarction

Itagaki, Y.; Nishitani, H., 1984:
CK-linked immunoglobulin in neuromuscular disorders

Cervoni, P.; Chan, P.S.; Lai, F.M.; Birnbaum, J.E., 1983:
CL 115,347 (DHV-PGE2 ME): a new orally and topically active prostaglandin antihypertensive agent

Villiger, J.W., 1984:
CL 218,872 binding to benzodiazepine receptors in rat spinal cord: modulation by gamma-aminobutyric acid and evidence for receptor heterogeneity

Gee, K.W.; Brinton, R.E.; Yamamura, H.I., 1983:
CL 218872 antagonism of diazepam induced loss of righting reflex: evidence for partial agonistic activity at the benzodiazepine receptor

Kantor, S.; Schenkel, R.H., 1984:
CL 259,971: a potent new polyether anticoccidial. 1. Battery efficacy and safety

Kantor, S.; Schenkel, R.H.; Kennett, R.L., 1984:
CL 259,971: a potent new polyether anticoccidial. 2. Floor-pen trials

Gussin, R.Z.; Cummings, J.R.; Stokey, E.H.; Ronsberg, M.A., 1969:
CL 65,562 (4-(a,a,a-trifluoro-m-toluidino)-nicotinic acid), a novel "high ceiling" diuretic

Rümke, C.L., 1964:
CL Rümke, 1898-1964

Gallant, D.M.; Bishop, M.P.; Guerrero-Figueroa, R., 1971:
CL-67,772: a preliminary evaluation of a potential antidepressant compound. Animal and human correlations

Mikhaĭlova, I.M., 1965:
CL. botulinum F. II. Biochemical properties. A study of toxin and toxoid formation

Cooke, E.D.; Bowcock, S.A.; Watkins, C.J.; Rustin, M.H.; Kirby, J.D., 1985:
CL115,347, an analogue of prostaglandin E2. Peripheral circulatory effects of single ascending doses administered transdermally in normal subjects and in patients with Raynaud's phenomenon

Bishop, C., 1981:
CLIS, a clinical laboratory information system designed to optimize microcomputer operation

Larin, A.I.; Kosumova, S.Iu., 1982:
CLinico-morphologic correlations in cases of fatal outcome following removal of acoustic nerve neuromas

Zub, K., 1967:
CLlinical treatment of the mixed tumors of the head (except parotid gland)

Sweeney, P., 1981:
CLosing in on employee retention

Krystal, G.; Eaves, C.J.; Eaves, A.C., 1984:
CM Affi-Gel Blue chromatography of human urine: a simple one-step procedure for obtaining erythropoietin suitable for in vitro erythropoietic progenitor assays

Kletsky, E.J.; Zwislocki, J.J., 1980:
CM tuning can be compatible with sharply tuned receptor potentials

Alexinsky, T.; Houcine, O., 1973:
CM-Pf thalamic complex and alimentary conditioning

Albano, D.; Giubbini, R.; Bertagna, F., 2018:
18F-FDG PET/CT in splenic marginal zone lymphoma

Anonymous, 1983:
CMA abortion survey

Brimacombe, G.G., 1995:
CMA and divisions consider payment options

Wallace, J.D., 1974:
CMA and its divisions form a complementary partnership

Wallace, J.D., 1973 :
CMA and provincial division roles

Anonymous, 1971:
CMA and the medical schools

Thomas, R.L., 1973:
CMA in action

Wallace, J.D., 1974:
CMA responds to challenge, helps shape change

Dunn, M., 1983:
CMA reviews physicians' administrative training needs

Wallace, J.D., 1974:
CMA statement offers a personal, moral commitment to every Canadian physician

Vidal, Vónica.; Albiach, C.; Gradolí, J.; Pérez, Jé.Leandro.; Montagud, V.; Belchí, J.; Morell, S.; Fácila, L., 2018:
18F-FDG PET/CT in the diagnosis of prosthetic valve endocarditis

Geekie, D.A., 1974:
CMA supports main conclusions of science council report--but

Stewart, B.; Routley, T.C., 1983:
CMA's Dr. T. Clarence Routley: 34 years of devoted service

Gray, C., 1983:
CMA's Speaker keeps you to the rules

Kaye, R.L., 1970:
CMA's certificate in continuing medical education

Anonymous , 1984:
CMA's preliminary submission to the House of Commons standing committee on health, welfare and social affairs

Anonymous, 1970:
CMA's proposal for a voluntary, universally available Health Benefits Program. A socio-economic report of the Bureau of Research and Planning, California Medical Association

Smith, G.H., 1984:
CMA-1284: the world's first "invisible precision attachment designed to maintain cranial motion

Gray, C., 1995:
CMA-cosponsored conference raises many questions about future of regionalized health care

Wallace, J.D., 1974:
CMA: medicine's coordinating voice

Morgan, P.P., 1983:
CMAJ's citation patterns

Anonymous, 1983:
CMB celebrations mark the end of an era

Wan, L.S.; Lee, P.F., 1974:
CMC of polysorbates

Safavi, K., 1973:
CMCP: a review of literature

Blanquaert, F.; Barritault, D.; Saffar, J.L.; Josefonvicz, J.; Caruelle, J.P., 1994:
CMDBS, functional analogs of sulfate heparanes, used as osseous cicatrizing agents

Marshall, C., 1981:
CMDNJ and postgraduate physician training in New Jersey

Bergen, S.S., 1973:
CMDNJ notes

Johnson, C.F., 1980:
CME and SKI-who is kidding whom?

Kerr, D.N., 1995:
CME and the JRCP(L): à la carte or table d'hôte?

Lifshen, M., 1995:
CME and you. State sets hours required for license renewal. Interview by Larry BeSaw

Correll, H.L., 1981:
CME credits and medical licensure

Houge, D.R., 1980:
CME evaluation -- 1979 Minnesota Medical Annual Meeting

Rosenthal, L.E., 1981:
CME examinations: one year of experience

Fenderson, D.A., 1982:
CME in Europe: family doctors lead the way

Berkshire, S.D., 1972:
CME in Indiana--a look before you leap

Tupper, R.L., 1984:
CME in Michigan is growing up

Sataloff, D.M.; Sataloff, R.T., 1984:
CME program. Tracheotomy and inhalation injury

White, B.C., 1981:
CME reporting standards should be rethought

Osteen, A.M., 1995:
CME requirements for Maryland medical license renewal

Anonymous, 1980:
CME requirements for license renewal

Thomison, J.B., 1984:
CME revisited; why Italy?

Peltonen, L., 1995:
CME--continuous medical education--a new label for quality in papers for Annals of Medicine

Markert, R.J.; Barton, J.; Rodin, A., 1982:
CME. How is it measuring up?

Johnson, M.E., 1980:
CME: a dynamic decade

Gottwald, G.; Szakolczai, I., 1983:
CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer

Bonadonna, G.; Rossi, A.; Tancini, G.; Valagussa, P.; Veronesi, U., 1984:
CMF adjuvant programs at the Milan Cancer Institute

Mouridsen, H.T.; Palshof, T.; Engelsman, E.; Sylvester, R., 1980:
CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial

De Placido, S.; Perrone, F.; Carlomagno, C.; Morabito, A.; Pagliarulo, C.; Lauria, R.; Marinelli, A.; De Laurentiis, M.; Varriale, E.; Petrella, G., 1995:
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study)

Heiman, E.M., 1980:
CMHC inpatient unit: private hospital for the poor?

Tourlentes, T.T., 1982:
CMHC productivity standards

Brill, N.Q., 1982:
CMHCs and the medical model

Sakamaki, T.; Kato, N.; Morimoto, M.; Hayashi, T.; Uzuki, H., 1984:
CMI and physical fitness of girls in a newly-established high school

Lipton, J.H.; Minden, M., 1995:
CML may not be part of HUS

Goulmy, E.; Persijn, G.G.; Blokland, E.; van Rood, J.J., 1981:
CML nonreactivity after kidney transplantation

Sugai, T.; Lin, C.H.; Shen, G.J.; Wong, C.H., 1995:
CMP-KDO synthetase: overproduction and application to the synthesis of CMP-KDO and analogs

Carey, D.J.; Sommers, L.W.; Hirschberg, C.B., 1980:
CMP-N-acetylneuraminic acid: isolation from and penetration into mouse liver microsomes

Tamari, M.; Maget-Dana, R.; Marmouyet, J.; Douste-Blazy, L., 1973:
CMP-aminoethylphosphonate: intermediary in the phosphonolipids of the rat liver

Bleasdale, J.E.; Johnston, J.M., 1982:
CMP-dependent incorporation of [14C]Glycerol 3-phosphate into phosphatidylglycerol and phosphatidylglycerol phosphate by rabbit lung microsomes

Berry, G.; Yandrasitz, J.R.; Segal, S., 1983:
CMP-dependent phosphatidylinositol:myo-inositol exchange activity in isolated nerve-endings

Wenkert, E.; Cochran, D.W.; Schell, F.M.; Archen, R.A.; Matsumoto, K., 1972:
CMR spectral analysis of tetrahydrocannabinol and its isomers

Lenzi, G.L.; Frackowiak, R.S.; Jones, T.; Heather, J.D.; Lammertsma, A.A.; Rhodes, C.G.; Pozzilli, C., 1981:
CMRO2 and CBF by the oxygen-15 inhalation technique. Results in normal volunteers and cerebrovascular patients

Whitesel, J.A., 1984:
CMS: successes, problems and solutions

Kerman, R.H.; Conklin, R.; Cahall, D.; Van Buren, C.T.; Kahan, B.D., 1983:
CMV and renal allograft survival

Thimons, J.J., 1995:
CMV retinitis treatment

Schrier, R.D.; Freeman, W.R.; Wiley, C.A.; McCutchan, J.A., 1994:
CMV-specific immune responses and HLA phenotypes of AIDS patients who develop CMV retinitis. HNRC Group. HIV Neurobehavioral Research Center

Anonymous, 1966:
CNA Board sanctions strike as bargaining tool

Anonymous, 1972:
CNA Congress 72

Anonymous, 1984 :
CNA connection. The Canada Health Act: new action plan

Bayer, D., 1995:
CNA in coalition to save community hospital

Anonymous, 1995:
CNA leaders propose bylaws changes, plan to leave ANA

Anonymous, 1980:
CNA project report. Development of a definition of nursing practice and standards for nursing practice

Anonymous, 1983:
CNA to intensify lobbying activities

Palaniswamy, S.S.; Borde, C.R.; Subramanyam, P., 2018:
18F-FDG PET/CT in the evaluation of cancer cervix: Where do we stand today?

Adam, E., 1981:
CNA's standards for nursing practice: an interpretation

Fraser, M., 1983:
CNAA-approved nursing courses

Meehan, J.D., 1973:
CNBDE: friend or foe?

Saran, A.; Govil, G., 1972:
CNDO calculations on the conformational structure of acetylcholine

Blizzard, A.C.; Santry, D.P., 1969:
CNDO-2 calculations of the electronic structure of the guanine-cytosine base pair: proton transfer in excited states

Lewis, T.P., 1969:
CNDO-2 calculations on the acidities of alkanes and saturated alcohols and the basicities of methylamines

Topp, W.C.; Christensen, B.G., 1974:
CNDO-2 study of the antibacterial activity of penicillins and cephalosporins

Welsh, W.J.; Cody, V.; Mark, J.E.; Zakrzewski, S.F., 1983:
CNDO/2 molecular orbital calculations on the antifolate DAMP and some related species: structural geometries, ring distortions, change distributions and conformational characteristics

O'Neill, P.C., 1971:
CNIB--a service for all seasons

Black, A., 1984:
CNJ talks to Alison Black, health educator. Interview by Judith Banning

Friesen, G., 1980:
CNJ talks to Gordon Friesen: on the other side of the angels.. Interview by Anne Besharah

Wheatley, S., 1981:
CNJ talks to Shirley Wheatley, independent nurse practitioner

Painter, S.L., 1982:
CNJ talks to... Susan Lee Painter, head, National Clearinghouse on Family Violence. Interview by Judith Banning

Donaho, B.A.; Goertzen, I.E., 1995:
CNO to CEO: Barbara A. Donaho and Irma E. Goertzen--they broke the glass ceiling. Interview by Barbara J Brown

Fitzgerald, B., 1981:
CNOR: the southern way

Bolelli, G.; Zucchelli, G.C.; Pilo, A.; Franceschetti, F.; Mimmi, P., 1982:
CNR external quality control for the assay of some steroids: results of the first half-year activity

Albertini, A.; Iacobello, C.; Pilo, A.; Pizzocolo, G.; Signorini, C.; Zucchelli, G.C., 1982:
CNR external quality control program for hLH, hFSH, hPRL and hCG: first-semester experience

Lima, G.M.; Matti, A.; Burgio, L.; Nanni, C.; Castellucci, P.; Fanti, S., 2017:
18F-FDG PET/CT scan confirmed by pathology findings in a singular case of squamous cell carcinoma of the epiglottis

Shugar, G., 1983:
CNS IgG synthesis in multiple sclerosis: choosing the right reference population

Holbach, K.H.; Gaddoni, G., 1971:
CNS Sarcoidosis as a neurosurgical clinical entity

Anonymous, 1969:
CNS abnormalities after hyperbilirubinemia

Hyman, C.B.; Keaster, J.; Hanson, V.; Harris, I.; Sedgwick, R.; Wursten, H.; Wright, A.R., 1969:
CNS abnormalities after neonatal hemolytic disease or hyperbilirubinemia. A prospective study of 405 patients

Elison, C.; Lien, E.J.; Zinger, A.P.; Hussain, M.; Tong, G.L.; Golden, M., 1971:
CNS activities of lactam derivatives

Koss, M.C.; Gherezghiher, T.; Nomura, A., 1984:
CNS adrenergic inhibition of parasympathetic oculomotor tone

Spitzer, J.J., 1973:
CNS and fatty acid metabolism

Jamieson, D.; Cass, N., 1967:
CNS and pulmonary damage in anesthetized rats exposed to hyperbaric oxygen

Opitz, J.M.; Gilbert, E.F., 1982:
CNS anomalies and the midline as a "developmental field"

Sherman, J.J.; Johnson, P.K., 1994:
CNS as unit-based case manager

Hebb, C., 1970:
CNS at the cellular level: identity of transmitter agents

Werman, R., 1972:
CNS cellular level: membranes

Bleyer, A., 1995:
CNS chemoradiotherapy of childhood leukemia: the plot thickens but the ending bodes well

Akaike, N., 1982:
CNS control of active sodium transport in muscle during progressive hypokalemia in the rat

Szafarczyk, A.; Ixart, G.; Alonso, G.; Malaval, F.; Nouguier-Soulé, J.; Assenmacher, I., 1983:
CNS control of the circadian adrenocortical rhythm

Lerman, V.J., 1983:
CNS cysticercosis revisited

Santilli, A.A.; Kim, D.H.; Fieber, R.A.; Wanser, S.V., 1974:
CNS depressant effects of Schiff bases derived from 4,6-dichloro-5-pyrimidinecarboxaldehydes and substituted anilines

Davies, G.K.; Tolhurst-Cleaver, C.L.; James, T.L., 1980:
CNS depression from intrathecal morphine

Wedig, J.H.; Gay, V.L.; Midgley, A.R., 1973:
CNS depression in the absence of prolactin release following intraarterial injections of sodium pentothal in the proestrous rat

Mullin, M.H.; Opperwall, B.C.; White, S.L., 1995:
CNS development of health maintenance programs: quality improvement and cost reduction

Roth, R.H., 1984:
CNS dopamine autoreceptors: distribution, pharmacology, and function

Mishra, R.K., 1984:
CNS dopamine receptors: effect of prolyl-leucyl-glycinamide and solubilization

Hori, A.; Orthner, H.; Kohlschütter, A.; Schott, K.M.; Hirabayashi, K.; Shimokawa, K., 1980:
CNS dysplasia in dysencephalia splanchnocystica (Gruber's syndrome). A case report

Vyas, D.S.; Madan, B.R., 1972:
CNS effects of 1-isopropylamino-3-(4-indanoxy)-2-propanol hydrochloride (USVC-6524)

Schmidt, D.E.; Wecker, L., 1981:
CNS effects of choline administration: evidence for temporal dependence

Itil, T.M.; Menon, G.N.; Bozak, M.M.; Itil, K.Z., 1984:
CNS effects of citalopram, a new serotonin inhibitor antidepressant (a quantitative pharmaco-electroencephalography study)

Fink, M., 1972:
CNS effects of convulsive therapy: significance for a theory of depressive psychosis

Sabelli, H.C., 1969:
CNS effects of local anesthetics only partially dependent on biogenic amine mechanisms

Katz, M.J., 1984:
CNS effects of mechanically produced spina bifida

Orzack, M.H.; Branconnier, R.; Gardos, G., 1973:
CNS effects of propranolol in man

Sabelli, H.C.; Giardina, W.J., 1970:
CNS effects of the aldehyde products of brain monoamines

Sandok, B.A.; von Estorff, I.; Giuliani, E.R., 1980:
CNS embolism due to atrial myxoma: clinical features and diagnosis

Hof, D.G.; Cline, W.H.; Dexter, J.D.; Mengel, C.E., 1972:
CNS epinephrine tone, a possible etiology for the threshold in susceptibility to oxygen toxicity seizures

Bradna, J., 1967:
CNS excitability changes during hyperventilation

Satterfield, J.H.; Cantwell, D.P., 1974:
CNS function and response to methylphenidate in hyperactive children

Wolf, M.K.; Billings-Gagliardi, S., 1984:
CNS hypomyelinated mutant mice (jimpy, shiverer, quaking): in vitro evidence for primary oligodendrocyte defects

Gorse, G.J.; Slater, L.M.; Sobol, E.; Kim, R.C.; Wishnow, R.M.; Cesario, T.C., 1984:
CNS infection and bacteremia due to clostridium septicum

Brill, C.B.; Pearlstein, L.S.; Kaplan, M.; Mancall, E.L., 1982:
CNS infections caused by Eikenella corrodens

Di Lena, C.; Toraldo, R., 1983:
CNS infections in the newborn infant

Levine, G.A.; Winkelstein, A.; Shadduck, R.K., 1973:
CNS involvement as the initial manifestation of acute leukemia

Raz, I.; Siegal, T.; Siegal, T.; Polliack, A., 1984:
CNS involvement by non-Hodgkin's lymphoma. Response to a standard therapeutic protocol

Mehta, Y.; Hendrickson, F.R., 1974:
CNS involvement in Ewing's sarcoma

Stavem, P.; Evensen, S.A., 1984:
CNS involvement in acute myelomonoblastic leukemia

Bojsen-Møller, M.; Nielsen, J.L., 1983:
CNS involvement in leukaemia. An autopsy study of 100 consecutive patients

Dumont, M.; Lamoureux, J.; Lamoureux, F.; Danais, S.; Soucy, J.P.; Dionne, D., 1983:
CNS involvement in lymphomatoid granulomatosis

Dastur, D.K.; Singhal, B.S.; Shroff, H.J., 1981:
CNS involvement in malignant atrophic papulosis (Kohlmeier-Degos disease): vasculopathy and coagulopathy

Jayakar, V.V.; Tilve, G.H.; Fernandes, R.J.; Rege, U.G.; Soman, R.N., 1980:
CNS involvement in mycosis fungoides

Hennemann, H.H.; Ranft, K.; Weiss, A.; Mantel, W.; Lengfelder, E., 1981:
CNS involvement in non-Hodgkin lymphomas. Clinical aspects and therapy

Wen, K.W.; Shih, L.Y.; Dunn, P., 1982:
CNS involvement in non-Hodgkin's lymphoma--clinical analysis of 24 cases

Brown, D.R.; Miller, R.J., 1983:
CNS involvement in the antisecretory action of [Met5]enkephalinamide on the rat intestine

Levitt, L.J.; Dawson, D.M.; Rosenthal, D.S.; Moloney, W.C., 1980:
CNS involvement in the non-Hodgkin's lymphomas

Giri, P.G., 1984:
CNS irradiation in small cell lung cancer

Naidu, S.; Messmore, H.; Caserta, V.; Fine, M., 1983:
CNS lesions in neonatal isoimmune thrombocytopenia

Jellinger, K.; Tarnowska-Dziduszko, E., 1971:
CNS lesions in olivo-ponto-cerebellar atrophies

Jellinger, K., 1974:
CNS lesions in prolonged disorders of responsiveness,

Kanner, S.P.; Wiernik, P.H.; Serpick, A.A.; Walker, M.D., 1970:
CNS leukemia mimicking multifocal leukoencephalopathy

Steinherz, P.G., 1995:
CNS leukemia: problem of diagnosis, treatment, and outcome

Chamberlain, M.C., 1995:
CNS lymphoma

Dagi, T.F.; Pevsner, P., 1984:
CNS lymphomatous deposits

Pietrzyk, J.J.; Grochowski, J.; Kańska, B., 1983:
CNS malformations in the Kraków region. I. Birth prevalence and seasonal incidence during 1979-1981

Freund, M.; Ostendorf, P.; Gärtner, V.H.; Waller, H.D., 1983:
CNS manifestations in non-Hodgkin lymphomas (NHL)

Cohen, M.S.; Kwei, H.E.; Chin, C.C.; Ge, H.C., 1983:
CNS manifestations of epidemic hemorrhagic fever. An advanced manifestation of disease associated with poor prognosis

Sobel, D.; Norman, D., 1984:
CNS manifestations of hereditary hemorrhagic telangiectasia

Bale, J.F.; Brasher, C.; Siegler, R.L., 1980:
CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis

McBride, W.J.; Murphy, J.M.; Gatto, G.J.; Levy, A.D.; Yoshimoto, K.; Lumeng, L.; Li, T.K., 1993:
CNS mechanisms of alcohol self-administration

Taché, Y.; Collu, R., 1982:
CNS mediated inhibition of gastric secretion by bombesin: independence from interaction with brain catecholaminergic, and serotoninergic pathways and pituitary hormones

Willner, J.; Bohndorf, W., 1995:
CNS metastases in malignant melanomas

Pappas, C., 1981:
CNS myelin and synapses in a spontaneous mouse ovarian teratoma showing neural differentiation. An immunohistochemical and electron microscopic study

Day, W.A., 1980:
CNS neurofilament proteolysis and the 58 000-dalton fragment

Emson, P.C., 1982:
CNS neuropeptides: implications for neuropharmacology

Gramsbergen, A.; Ijkema-Paassen, J., 1982:
CNS plasticity after hemicerebellectomy in the young rat. Quantitative relations between aberrant and normal cerebello-rubral projections

Guin, S.E., 1995:
CNS practice in neurosurgery

Ashwal, S.; Hinshaw, D.B.; Bedros, A., 1984:
CNS primitive neuroectodermal tumors of childhood

Castel, V.; Ferris, J.; Prats, C., 1980:
CNS prophylaxis in acute lymphoblastic leukemia

Komp, D.M.; Fernandez, C.H.; Falletta, J.M.; Ragab, A.H.; Humphrey, G.B.; Pullen, J.; Moon, T.; Shuster, J., 1982:
CNS prophylaxis in acute lymphoblastic leukemia: comparison of two methods a Southwest Oncology Group study

Chiu, S.; Ferris, J.A.; Johnson, R.; Mishra, R.K., 1982:
CNS putative L-prolyl-L-leucyl-glycinamide (PLG) receptors, brain and lymphocyte dopamine receptors

Söderman, P.; Sahlberg, D.; Wiholm, B.E., 1984:
CNS reactions to nose drops in small children

Dicus, R.G., 1973:
CNS regeneration research

Heller, H.C.; Hammel, H.T., 1971:
CNS regulation of body temperature in the hibernator Citellus lateralis

Steffens, A.B.; Strubbe, J.H., 1983:
CNS regulation of glucagon secretion

Renaud, L.P.; Day, T.A.; Ferguson, A.V., 1984:
CNS regulation of reproduction: peptidergic mechanisms

Peto, J., 1981:
CNS relapse in childhood leukaemia

Imle, M.A., 1995:
CNS research: variables of interest and reasons for being

Inaba, K., 1995:
CNS role continues to evolve in Oregon

Brubakken, K.M.; Janssen, W.R.; Ruppel, D.L., 1994:
CNS roles in implementation of a differentiated case management model

Cameron, A.S.; Pearson, C., 1982:
CNS signs associated with campylobacter enterocolitis

Fuller, R.W.; Snoddy, H.D.; Molloy, B.B.; Hauser, K.M., 1973:
CNS stimulant properties and physiologic disposition of , -difluorophenylethylamine in mice

Lake, C.R.; Quirk, R.S., 1984:
CNS stimulants and the look-alike drugs

Jordan, P.S., 1981:
CNS stimulants sold as amphetamines

Divinetz Romero, S.; Wang, J.Y.; Yaksh, T.L., 1984:
CNS stimulation and PGE2 release. I. Depolarizing agents

Shashoua, V.E.; Wolf, M.K., 1971:
CNS tissue cultures: changes in the ratio of incorporation of leucine and valine into proteins during myelinogenesis

Fruncillo, R.J.; Gibbons, W.; Bowman, S.M., 1982:
CNS toxicity after ingestion of topical lidocaine

Levin, V.A.; Byrd, D.; Campbell, J.; Davis, R.L.; Borcich, J.K., 1984:
CNS toxicity and CSF pharmacokinetics of intraventricular DFMO and MGBG in beagle dogs

Dunnett, S.B.; Björklund, A.; Stenevi, U.; Iversen, S.D., 1982:
CNS transplantation: structural and functional recovery from brain damage

Perini, S.; Beltramello, A.; Pasut, M.L.; Benati, A.; Bricolo, A., 1984:
CNS trauma: head injuries

Young, S.N.; Lal, S., 1980:
CNS tryptamine metabolism in hepatic coma

Gerlach, H.; Jänisch, W.; Schreiber, D., 1982:
CNS tumors of the perinatal period

Vilchez-Padilla, J.J.; Redon, J.; Ruiz, A.; Lopez-Aldeguer, J., 1982:
CNS varicella-zoster vasculitis

Collins, R.C.; Chernik, N.L.; Posner, J.B., 1974:
CNS vascular disease in patients with cancer

Mohan, R.R.; Agarwal, C.; Agarwal, R.; Misra, V.S., 1984:
CNS, anthelmintic and antiinflammatory activities of some 1-[2/3-(2-phenyl benzimidazole)]2-methyl/phenyl-4-(3,4-disubstituted benzylidene)5-oxo-imidazoles

Bradley, D.J.; Fox, M.; Williams, T.D., 1972:
CNS--an on-line program for controlling stereotaxic stimulation within the central nervous system, and for recording and analysis of responses in a neurophysiological experiment

Mukerji, D.D.; Nautiyal, S.R.; Prasad, C.R.; Dhawan, B.N., 1980:
CNS-depressant activity of some newly synthesised 4(3H)-quinazolones

Sundgren, P.; Bååth, L.; Maly, P., 1995:
CNS-effects from subarachnoid injections of iohexol and the non-ionic dimers iodixanol and iotrolan in the rabbit

Hyvärinen, J., 1973:
CNS: afferent mechanisms with emphasis on physiological and behavioral correlations

Beecroft, P.C., 1994:
CNS: thriving or heading for extinction?

Duffield, C.; Donoghue, J.; Pelletier, D., 1995:
CNSs' perceptions of role competencies: one Australian perspective

Brunia, C.H.; Vingerhoets, A.J., 1980:
CNV and EMG preceding a plantar flexion of the foot

Timsit-Berthier, M.; Gerono, A.; Rousseau, J.C., 1980:
CNV and functional state changes during long-lasting and repetitive recording sessions

Rizzo, P.A.; Albani, G.F.; Caporali, M.; Pierelli, F.; Spadaro, M.; Zanasi, M.; Morocutti, C., 1980:
CNV and hypnotic regression

Doroshenko, V.A.; Kirdjankin, A.T.; Smirnov, V.A., 1981:
CNV and motor preparatory set processes under conditions of alternative responding in man

Tecce, J.J.; Savignano-Bowman, J.; Dessonville, C.L., 1984:
CNV and myogenic functions. I. Muscle tension produces a dissociation of CNV and EMG

Tecce, J.J.; Cattanach, L.; Boehner-Davis, M.B.; Clifford, T.S., 1984:
CNV and myogenic functions. II. Divided attention produces a double dissociation of CNV and EMG

Macar, F.; Vitton, N., 1980:
CNV and reaction time task in man: effects of inter-stimulus interval contingencies

Abramovitz, M.; Dubrovsky, B., 1980:
CNV characteristics throughout the normal menstrual cycle

Delse, F.C.; Marsh, G.R.; Thompson, L.W., 1972:
CNV correlates of task difficulty and accuracy of pitch discrimination

Karrer, R.; McDonough, B.; Warren, C.; Cone, R., 1980:
CNV during memory retrieval by normal and retarded adults

Tecce, J.J.; Cattanach, L.; Yrchik, D.A.; Meinbresse, D.; Dessonville, C.L., 1982:
CNV rebound and aging

Tecce, J.J.; Yrchik, D.A.; Meinbresse, D.; Dessonville, C.L.; Cole, J.O., 1980 :
CNV rebound and aging. I. Attention functions

Tecce, J.J.; Yrchik, D.A.; Meinbresse, D.; Dessonville, C.L.; Clifford, T.S.; Cole, J.O., 1980:
CNV rebound and aging. II. Type A and B CNV shapes

Small, J.G.; DeMyer, M.K.; Milstein, V., 1971:
CNV responses of autistic and normal children

Walker, D.A.; McCormick, A.V.; Stokes, D.M., 1971:
CO 2 -dependent oxygen evolution by envelope-free chloroplasts

Vidal, M.C.; Cazzulo, J.J., 1972:
CO 2 -fixing enzymes in a marine psychophile

Breitwieser, P.; Herbrich, H.; Nöske, H.D.; Zimmermann, H.D.; Kraushaar, J.; Temme, H., 1973:
CO 2 -laser as a surgical instrument in experimental urology

Bursaux, C.D.; Poyart, C.F.; Freminet, A.; Bursaux, E.; Dubois, C., 1972:
CO 2 and electrolytes of bone. Influence of growth on the mineral composition of the rat femur

Meyer, O.E., 1972:
CO 2 double effects in the Paradentospray system

Piiper, J.; Scheid, P.; Teichmann, J.; Adaro, F., 1972:
CO 2 equilibration between alevolar gas and pulmonary capillary blood during rebreathing

Glen, J.B.; Scott, W.N., 1972:
CO 2 euthanasia in cats

Jansz, E.R.; Maclean, F.I., 1973:
CO 2 fixation by the blue-green alga Anacystis nidulans

Sarno, A.; Caimi, G.; Amuso, M.; Adamo, M., 1973:
CO 2 gradient in mitral valve diseases

Schilb, T.P.; Brodsky, W.A., 1972:
CO 2 gradients and acidification by transport of HCO 3 in turtle bladders

Petty, W.C.; Sulkowski, T.S., 1971:
CO 2 narcosis in the rat. 1. Effects on respiration and blood parameters

Petty, W.C.; Sulkowski, T.S., 1971:
CO 2 narcosis in the rat. II. Effects on the ECG

McLaren, A.; Menke, T.M., 1971:
CO 2 output of mouse blastocysts in vitro, in normal pregnancy and in delay

Kiesow, L.A.; Shelton, J.B.; Bless, J.W., 1972:
CO 2 partial pressure and enthalpy and thermodynamic efficiency of the oxidation of nitrite by Nitrobacter

Bertermann, H.; Kusche, B.; Schirmer, A., 1972:
CO 2 production from 14 C -labelled substrates by isolated kidney cells

Thauer, R.K., 1973:
CO 2 reduction to formate in Clostridium acidi-urici

Maruyama, M.; Masuko, K.; Kato, A.; Takahashi, S.; Ichiyanagi, K., 1971:
CO 2 uptake in vivo. 2. Effect of altered cardiac output on the chronological change in total body (HCO 3 ) in acute hypercapnia in dogs

Borison, H.L.; McCarthy, L.E., 1973:
CO 2 ventilatory response time obtained by inhalation step forcing in decerebrate cats

Spiro, T.G., 1995:
CO binding and bending energetics

Clore, G.M.; Chance, E.M., 1980:
CO binding to mitochondrial mixed valence state cytochrome oxidase at low temperatures

Sybert, A.; Ayash, R.; Chatham, M.; Gurtner, G.H., 1982:
CO concentration-dependent changes in pulmonary diffusing capacity in humans

Albu, A.; Schuleri, E., 1972:
CO diffusion through the alveolocapillary membrane in patients with occupational pulmonary siderosis

Ramón Soler, R.; Baixarias Gascón, P.; Mas Marfany, J., 1980:
CO poisoning. Hyperbaric oxygen and barbiturates

Symanski, H., 1971:
CO poisoning: diagnosis, therapy and prognosis

Kawashiro, T., 1983:
CO pulmonary diffusing capacity

Gontier, F., 1969:
CO-2 gas welding

Fazzini, G.; Mantovani-Orsetti, G.; Zangrando, O.; Toppan, A.; Taboga, V.; Segato, G., 1964:
CO-2, O-2] and pH determined in the lymph and in venous and arterial blood of the dog

Berne, A.S.; Ikins, P.M.; Bugden, W.F., 1967:
CO-2-O-2 pneumomediastinography with polytomography for the preoperative evaluation of bronchogenic carcinoma

Krishnamurthi, S., 1965:
CO-60 beam therapy in cancer of the thoracic esophagus

Miller, D.J.; Wood, P.M., 1983:
CO-binding c-type cytochromes and a high-potential cytochrome c in Nitrosomonas europaea

Brown, H.D.; Morris, H.P.; Chattopadhyay, S.K.; Patel, A.B.; Pennington, S.N., 1969:
CO-binding pigment (P-450) and other electron transport components in hepatoma bearing rats

Hilpert, P.; Bähr, R.; Junger, H.; Rosendahl, W., 1973:
CO-diffusion capacity, compliance and lung volumes after hyperbaric oxygenation

Brautaset, N.J., 1980:
CO-intoxication, an unusual case history

Snella, M.C.; Rylander, R.; Landry, J.C., 1980:
CO-pollution, a health risk in Geneva?

Ding, A.H., 1983:
CO2 Laser treatment of atypical hyperplasia of uterine cervix (with a 5-year follow-up of 107 cases)

Luich, R.J., 1983:
CO2 absorber malassembly

Morrow, J.S.; Keim, P.; Gurd, F.R., 1974:
CO2 adducts of certain amino acids, peptides, and sperm whale myoglobin studied by carbon 13 and proton nuclear magnetic resonance

Wasterlain, C.G., 1970:
CO2 anaesthesia inhibits RNA synthesis

Kawakami, Y., 1982:
CO2 and O2 ventilatory responses

Winters, R.W., 1972:
CO2 and acid-base reactions. Introduction: terminology of acid-base disorders

Case, R.B., 1981:
CO2 and coronary flow regulation

Moss, I.R.; Scarpelli, E.M., 1984:
CO2 and naloxone modify sleep/wake state and activate breathing in the acute fetal lamb preparation

Lagneaux, D.; Lecomte, J.; Remacle, R.; Volon, G., 1980:
CO2 and the catecholamine content of the adrenal medulla of the rat

Battistini, A.; Waring, W.W., 1970:
CO2 arterial-alveolar difference in the course of cystic fibrosis

Koch, W., 1969:
CO2 arthrography of the hip joint in children

Veres, J., 1968:
CO2 chamber. The effect of CO2 gas chamber therapy on obliterative arterial diseases, using natural solid CO2 of Répcelak

Ryan, E.L., 1995:
CO2 concentrations in the environment of sleeping infants

Maryniak, O., 1982:
CO2 cystometry in myelodysplasia

Matthews, P.N.; Bidgood, K.A.; Woodhouse, C.R., 1984:
CO2 cystoscopy using a flexible fibreoptic endoscope

Kidder, G.W.; Montgomery, C.W., 1974:
CO2 diffusion into frog gastric mucosa as rate-limiting factor in acid secretion

Totsuka, T., 1965:
CO2 diffusion resistance and rate of photosynthesis

Hawkins, I.F.; Caridi, J.G., 1995:
CO2 digital subtraction arteriography--advantages and current solutions for delivery and imaging

Wick, H., 1969:
CO2 dilates the pulmonary alveoli

Margenet, A.; Romano, P.; Teisseire, B.; Huguenard, P., 1981:
CO2 during artificial ventilation in patients undergoing neuroplegia. Effects on gas exchange

Kong, M.Cindy.; Nadel, H.Ruth., 2018:
18F-FDG PET/CT With Diffusely High FDG Uptake Throughout Subcutaneous Adipose Tissues

Goldstein, D.; Slutsky, A.S.; Ingram, R.H.; Westerman, P.; Venegas, J.; Drazen, J., 1981:
CO2 elimination by high frequency ventilation (4 to 10 Hz) in normal subjects

Rossing, T.H.; Slutsky, A.S.; Ingram, R.H.; Kamm, R.D.; Shapiro, A.H.; Drazen, J.M., 1982:
CO2 elimination by high-frequency oscillations in dogs--effects of histamine infusion

Malnic, G., 1980:
CO2 equilibria in renal tissue

Freed, D.L., 1983:
CO2 euthanasia

Gulyi, M.F.; Mikhailovskaia, L.M.; Zhurbin, G.I.; Gruzova, L.M.; Stognii, N.A., 1973:
CO2 fixation (carboxylation) and blood regeneration in rabbits with experimental posthemorrhagic anemia

Donawa, A.L.; Ishaque, M.; Aleem, M.I., 1973:
CO2 fixation and metabolic control in Pseudomonas saccharophila

Roon, R.J.; Levenberg, B., 1970:
CO2 fixation and the involvement of allophanate in the biotin-enzyme-catalyzed cleavage of urea

Linke, H.A., 1969:
CO2 fixation by Clostridium aceticum: short-term 14CO2 incorporation and pyruvate metabolism

Matula, T.I.; McDonald, I.J.; Martin, S.M., 1969:
CO2 fixation by malic enzyme in a species of Micrococcus

Gulyĭ, M.F., 1971:
CO2 fixation by microorganisms and other heterotrophic organisms and its physiological significance

McCarthy, J.T.; Charles, A.M., 1974:
CO2 fixation by the facultative autotroph Thiobacillus novellus during autotrophy-heterotrophy interconversions

Naruse, H.; Cheng, S.C.; Waelsch, H., 1966:
CO2 fixation in the nervous system. V. CO2 fixation and citrate metabolism in rabbit nerve

Cheng, S.C., 1971:
CO2 fixation in the nervous tissue

Naruse, H.; Cheng, S.C.; Waelsch, H., 1966:
CO2 fixation in the nervous tissue. IV. CO2 fixation and citrate metabolism in lobster nerve

Putilina, F.E.; Osadchaia, L.M., 1980:
CO2 fixation reactions and their role in brain lipogenesis

Fuchs, G.; Thauer, R., 1974:
CO2 fixation via direct CO2 reduction: a molybdenum dependent reaction

Tsujikawa, H.; Ogoshi, S.; Iizuka, Y.; Nakamura, S.; Yokoyama, M., 1969:
CO2 flooding in the chest during open heart surgery

Rapoport, S.; Müller, M., 1967:
CO2 formation from formate in red blood cells

Rapoport, S.; Schultze, M., 1968:
CO2 formation from glycerin in rabbit reticulocytes

Ryan, E.L., 1994:
CO2 in the environment of sleeping infants

Wright, V.C.; Riopelle, M.A.; Rubinstein, E.; Rylander, E.; Joelsson, I., 1984:
CO2 laser and cervical intraepithelial neoplasia

Janczewski, G.; Sonnenberg, Z.; Połubiński, R., 1982:
CO2 laser as a surgical instrument

Panzoni, E.; Clauser, C., 1981:
CO2 laser as an instrument for osteotomy

Riedel, H.H.; Semm, K., 1982:
CO2 laser coagulation of benign changes of the portio vaginalis in comparison with the endocoagulation technic (Semm's method)

Meandzija, M.P.; Locher, G.; Jackson, J.D., 1984:
CO2 laser conization versus conventional conization: a clinico-pathologic appraisal

Simonsen, E.; Johnsson, J.E.; Tropé, C., 1983:
CO2 laser for the treatment of invasive vulvar and vaginal cancer

Baggish, M.S.; Dorsey, J.H., 1981:
CO2 laser for the treatment of vulvar carcinoma in situ

Dorigo, E.; Gariatti, M.; Telesca, G., 1984:
CO2 laser in continuous application and on dental hard tissues

Berget, A.; Larsen, J.F.; Pedersen, P.H.; Olesen, M.B.; Aarup, I., 1982:
CO2 laser in gynecology. Clinical experience

Larsen, J.F.; Berget, A.; Pedersen, P.H.; Olesen, M.B., 1982:
CO2 laser in gynecology. I. Description of a new method of operation

Annyas, A.A.; Van Overbeek, J.J.; Escajadillo, J.R.; Hoeksema, P.E., 1984:
CO2 laser in malignant lesions of the larynx

Dorigo, E.; Bariatti, M.; Telesca, G., 1984:
CO2 laser in non continuous application to dental hard tissues

Ossoff, R.H.; Hotaling, A.J.; Karlan, M.S.; Sisson, G.A., 1983:
CO2 laser in otolaryngology-head and neck surgery: a retrospective analysis of complications

Opala, T.; Wozniak, J.; Pisarska-Krawczyk, M.; Wilczak, M.; Guglas, E.; Pisarski, T., 1994:
CO2 laser in treatment of uterine cervix dysplasia in women with infertility

Karlin, D.B.; Patel, C.K.; Wood, O.R.; Llovera, I., 1980:
CO2 laser in vitreoretinal surgery

Kelly, R.W.; Roberts, D.K., 1983:
CO2 laser laparoscopy. A potential alternative to danazol in the treatment of stage I and II endometriosis

Bailin, P.L.; Ratz, J.L.; Lutz-Nagey, L., 1981:
CO2 laser modification of Mohs' surgery

Goode, R.L., 1982:
CO2 laser myringotomy

Gaboriau, H.; Laccourreye, O.; Laccourreye, H.; Brasnu, D., 1995:
CO2 laser posterior transverse cordotomy for isolated type IV posterior glottic stenosis

Bromm, B.; Treede, R.D., 1983:
CO2 laser radiant heat pulses activate C nociceptors in man

McGee, K.C.; Nagle, J.W.; Toohill, R.J., 1981:
CO2 laser repair of subglottic and upper tracheal stenosis

Apfelberg, D.B.; Maser, M.R.; Lash, H.; Druker, D., 1983:
CO2 laser resection for giant perineal condyloma and verrucous carcinoma

Gardner, G.; Robertson, J.H.; Tomoda, K.; Clark, W.C., 1984:
CO2 laser stapedotomy: is it practical?

Smailagic, N.; Lafortune, L.; Kelly, S.; Hyde, C.; Brayne, C., 2018:
18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy

Somma, A.M.; Dioguardi, D., 1982:
CO2 laser surgery in recurrent tumors of the nose

Frame, J.W., 1984:
CO2 laser surgery in the mouth

Finkelstein, L.H., 1984:
CO2 laser surgery in urology

Schick, R.O.; Schick, M.P., 1994:
CO2 laser surgery in veterinary dermatology

Stein, S., 1984:
CO2 laser surgery of the cervix, vagina, and vulva

Keane, W.M.; Atkins, J.P., 1984:
CO2 laser surgery of the upper airway

Heiden, B.T.; Chen, G.; Hermann, M.; Brown, R.K.J.; Orringer, M.B.; Lin, J.; Chang, A.C.; Carrott, P.W.; Lynch, W.R.; Zhao, L.; Beer, D.G.; Reddy, R.M., 2018:
18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer

Piquet, J.J.; Darras, J.A.; Buisset, E., 1982:
CO2 laser treatment of laryngopyocele

Horch, H.H.; Gerlach, K.L., 1982:
CO2 laser treatment of oral dysplastic precancerous lesions: a preliminary report

Ratz, J.L.; Bailin, P.L.; Levine, H.L., 1982:
CO2 laser treatment of port-wine stains: a preliminary report

Sawchuk, W.S.; Heald, P.W., 1984:
CO2 laser treatment of trichoepithelioma with focused and defocused beam

Mittelman, H., 1982:
CO2 laser turbinectomies for chronic, obstructive rhinitis

Rubinstein, E., 1983:
CO2 laser versus cryotherapy

Rosemberg, S.K., 1984:
CO2 lasers in urology

Fava, G.; Emanuelli, H.; Cascinelli, N.; Bandieramonte, G.; Canestri, F.; Marchesini, R., 1983:
CO2 lasers: beam patterns in relation to surgical use

Gray, F.N., 1984:
CO2 lasers: everything you wanted to know about lasers--and more!

Filippov, M.M.; Miniaĭlenko, T.D., 1980:
CO2 mass transfer and acid-base balance under conditions of muscular activity at sea level and in the mountains

Rognstad, R., 1983:
CO2 metabolism in the liver

Jaffe, T.B.; Bernhart, J., 1982:
CO2 monitoring during cardiopulmonary bypass

Karlmark, B., 1980:
CO2 permeability of the nephron in relation to the nature of luminal fluid acidification

Nations, C.; Hicks, T.C.; Ubelaker, J.E., 1973:
CO2 production by extracts of Hymenolepis diminuta (Cestoda: Hymenolepididae) with aspartate and -ketoglutarate as substrates

Park, H.C.; Leal-Pinto, E.; MacLeod, M.B.; Pitts, R.F., 1974:
CO2 production from plasma free fatty acids by the intact functioning kidney of the dog

Yamamura, H., 1974:
CO2 rebreathing in anesthesia

Campbell, R.L.; Shamaskin, R.G.; Gaskins, C.E., 1982:
CO2 rebreathing in the modified Bain circuit for conscious sedation and general anesthesia

Thauer, R.K.; Fuchs, G.; Schnitker, U.; Jungermann, K., 1973:
CO2 reductase from Clostridium pasteurianum: molybdenum dependence of synthesis and inactivation by cyanide

Thauer, R.K., 1972:
CO2 reduction to formate using NADPH

Barthelemy, R.; Puel, P.; Enjalbert, A.; Trudell, L.A.; Richardson, P.D.; Galletti, P.M., 1982:
CO2 removal through a microporous membrane lung

Schwartz, J.H.; Steinmetz, P.R., 1971:
CO2 requirements for H+ secretion by the isolated turtle bladder

Nakagawa, Y., 1982:
CO2 response of the brain stem circulation and the intracranial pressure in experimental hydrocephalus

Coleman, M.; Kapsen, T.; Gordon, M.; Boros, S., 1983:
CO2 responses in infants: on-line display and analysis using a microcomputer and waveform analyzer

McDowall, D.G.; Ali, M.M.; Lane, R.; Okuda, Y., 1974:
CO2 responsiveness of the cerebral circulation during halothane-induced hypotension in the baboon

Bodammer, G., 1973:
CO2 sensitivity as a physiological parameter

Wurst, H.; Schulte-Steinberg, H.; Finsterer, U., 1995:
CO2 stores in laparoscopic cholecystectomy with CO2 pneumoperitoneum

Gfeller, R.J., 1982:
CO2 urethroscopy and urethrocystometrics in office gynecology

Brandi, G.; Clode, M., 1969:
CO2 washout during hyperventilation in man

Boixeda, P.; Sánchez-Miralles, E.; Azaña, J.M.; Arrazola, J.M.; Moreno, R.; Ledo, A., 1994:
CO2, argon, and pulsed dye laser treatment of angiofibromas

Kogan, A.Kh.; Manuĭlov, B.M.; Grachev, S.V.; Bolevich, S.; Tsypin, A.B.; Daniliak, I.G., 1994:
CO2--a natural inhibitor of active oxygen form generation by phagocytes

Kogan, A.Kh.; Manuĭlov, B.M.; Grachev, S.V.; Bolevich, S.; Tsypin, A.B.; Daniliak, I.G., 1995:
CO2--a natural inhibitor of the generation of active species of oxygen in phagocytes

Ascher, P.W.; Heppner, F., 1984:
CO2-Laser in neurosurgery

Knoche, E.; Dick, W.; Traub, E.; Milewski, P., 1980:
CO2-bupivacaine for continuous epidural anesthesia in obstetrics

Spaich, P.; Usinger, W.; Albers, C., 1969:
CO2-combining curve and buffer capacity of the intracellular fluid

Aleksic, S.; Bockemühl, J.; Knobloch, J.; Hammann, R., 1982:
CO2-dependent mutant of Salmonella typhi causing typhoid fever in two patients

Bertsch, A., 1967:
CO2-gas exchange, water potential and saturation deficit in drying of epidermis-free leaf slices from Valerianella

Semm, K.; Rinkus, V., 1974:
CO2-hysteroscopy: technical considerations

Haddad, G.G.; Leistner, H.L.; Epstein, R.A.; Epstein, M.A.; Grodin, W.K.; Mellins, R.B., 1980:
CO2-induced changes in ventilation and ventilatory pattern in normal sleeping infants

Schreiber, G.; Oswald, H.; Danz, M.; Freund, E.; Staupendahl, G., 1974:
CO2-laser effects on peripheral medullated nerves

Skobelkin, O.K.; Brechov, J.I.; Smoljaninov, M.W.; Baschilov, W.P.; Petruschkov, W.W., 1982:
CO2-laser in surgery of infected soft tissue of the extremities (animal experiments)

Skobelkin, O.K.; Litwin, G.D.; Brechov, J.I.; Parchomenko, J.G.; Safronov, A.M.; Baschilov, W.P., 1982:
CO2-laser scalpel in surgery of parenchymous organs. Animal experiments

Höfler, H., 1983:
CO2-laser surgery in otorhinolaryhgology

Kryger-Baggesen, N.; Falck Larsen, J.; Hjortkjaer Pedersen, P., 1984:
CO2-laser treatment of condylomata acuminata

Bertermann, H.; Franke, H.; Huland, H.; Weiss, C., 1973:
CO2-production by the isolated perfused rat kidney from 14C-labelled substrates

Schweiger, O.; Dubay, M., 1980:
CO2-production of circulating lymphocytes in the presence of a sarcoidosis extract in patients with sarcoidosis

Geisler, L.; Herberg, D.; Schönthal, H., 1967:
CO2-reaction curves in patients with Pickwick syndrome

Lehmann, K.A.; Neubauer, M.L.; Daub, D.; Kalff, G., 1983:
CO2-response curves as a measure of opiate-induced respiratory depression. Studies with fentanyl

Friedman, P.A.; Andreoli, T.E., 1982:
CO2-stimulated NaCl absorption in the mouse renal cortical thick ascending limb of Henle. Evidence for synchronous Na +/H+ and Cl-/HCO3- exchange in apical plasma membranes

Hayashi, F.; Yoshida, A.; Fukuda, Y.; Honda, Y., 1982:
CO2-ventilatory response of the anesthetized rat by rebreathing technique

Bernstine, H.; Domachevsky, L.; Nidam, M.; Goldberg, N.; Abadi-Korek, I.; Shpilberg, O.; Groshar, D., 2018:
18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC)

Stavros, G.E., 1973:
CODAC--community organization for drug abuse control

Zubrzycka, H., 1984:
CODOFIX elastic mesh dressings

Davis, G., 1983:
COE dealing with statewide nursing ed plan, entry-into-practice and competencies

Nevin, J.J., 1971 :
COE self-balancing posteriors

Erhardson, S.; Johansson, E.G., 1969:
COE-comfort as impression material. A laboratory study about two essential properties

Molnar, E.J., 1971:
COE-pak and TEM-coe

Heider, G.; Ayoub, N.N.; Knöpke, C.; Glathe, H.; Ebner, D., 1973:
COFAL Test. 2. Demonstration of group specific antigens in avian sarcoma and leukosis viruses using chick embryo fibroblast tissue culture

Lewis, R.; Harrison, J., 1973:
COHR-what is it, where is it going?

Packham, H., 1980:
COHSE 1980: a look at what's to come

Bosanquet, N., 1980:
COHSE 1980: a necessary evil?

Salvage, J., 1980:
COHSE 1980: crisis of costs?

Vaughan, G., 1980:
COHSE 1980: man at the top. Interview by Andrew Brown

Anderson, G., 1982:
COHSE 1982: from women's rights to social rites

Anonymous, 1980:
COHSE Annual Conference

Packham, H., 1981 :
COHSE conference? A cosy meeting?

Gaze, H., 1984:
COHSE preview. Care at the crossroads

Flood, J., 1984:
COHSE preview. Following in father's footsteps?. Interview by Caroline Howie

Ross, T., 1984:
COHSE preview. Playing the numbers game

Brown, A., 1980:
COHSE: pioneers from the past

Stupfel, M.; Mordelet-Dambrine, M.; Vauzelle, A., 1981:
COHb formation and acute carbon monoxide intoxication in adult male rats and guinea-pigs